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Abstract:
The neuronal cytoskeleton is responsible for governing dynamics such as neurite extension
and cortex development. In particular, microtubules (MTs) and their associated proteins, and
molecular motors, have been shown to be critical in many neuronal processes such as intracellular
molecular transport and neuron differentiation. The fibroblast growth factors (FGFs) act as
powerful morphogens that have been shown to play a role in regulating cortical development.
FGFs activate receptor tyrosine kinases, of which fibroblast growth factor receptor substrate 3
(FRS3) has been shown to interact with, to mediate downstream signaling cascades (regulating cell
proliferation and differentiation). In addition to FRS3 and its role in signaling, preliminary
evidence suggested that FRS3 is a novel MT binding protein, and also interacts with MT
associated proteins and the molecular motor kinesin. Furthermore, the expression of FRS3 has
been shown to coincide with migrating cortical neurons from E12 cortical precursor cell cultures.
This thesis hypothesized that FRS3 regulates the differentiation and maturation of neurons as
well as post-mitotic neuron function by regulating MT stability and intracellular transport of
cargo and organelles. The research presented here has addressed this hypothesis in a multidisciplinary manner. First, FRS3 and its MT binding properties and its interactions with various
proteins involved in molecular transport within cortical and hippocampal neurons (including
motors, adapters and cargo) were investigated. FRS3 was shown to interact with markers of
migrating and post-mitotic neurons (acetylated alpha and Beta III tubulin, respectively), postsynaptic density scaffolding proteins (Shank 2 and 3), cargo (Flg/FGFR1), molecular motor
components (Kinesin Heavy Chain and Kinesin Light Chain), synaptic vesicle proteins (Syntaxin I
and Synaptophysin) and finally MT associated proteins
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(MAP2, Doublecortin and Tau). Next, loss of FRS3 expression in SN56 cells resulted in increased
sensitivity to the MT depolymerizing agent nocodazole, suggesting FRS3 is necessary for proper
MT dynamics. Furthermore, loss of FRS3, but not the related signaling adaptor FRS2, resulted in
impaired neurite outgrowth in both hippocampal and cortical cell culture. These results, taken
together, suggest that FRS3, in addition to its role in FGF signaling, also interacts with members of
the molecular transport machinery and confers stability to microtubules.

Keywords: Microtubules, FRS3, stability, molecular transport, neurite outgrowth, FGF,
cytoskeleton
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Chapter 1: Introduction

1.1 Function and Activity of Neurons

Neurons are the basic constituents of the brain. These specialized, highly polarized cells are
electrically excitable and responsible for processing and transmitting information in the form of
electric and chemical signals via intricate synapse networks (Huang and Reichardt, 2006). The ability
of neurons to polarize is essential for synaptic transmission (Conde, C. and Caceres, A., 2009).
Information is relayed amongst neurons through the conduction of action potentials. Action potentials
are a series of short lasting changes within the electrical membrane potential of a cell (Lodish et al.,
2004). The action potential originates at the base of the axon and cell body, referred to as the axon
hillock, and travels along the axon to the axon terminals where connections are made with adjacent
cells. Upon reaching the synaptic terminal, voltage sensitive Ca2+ channels allow for an influx of Ca2+,
thereby increasing the local concentration and stimulating the synaptic vesicles (containing
neurotransmitters) to be released into the synaptic cleft (space between adjacent, connecting neurons)
(Lodish et al., 2004).

1.2 The Anatomy of a Neuron
Neurons are composed of 4 distinct regions, all of which play a different role in the
communication of information throughout the brain. There is a wide variety in the shape, size and
electrochemical properties of any given neuron, given the diversity of functions performed by neurons
in various parts of the brain. As an example, the cell soma can vary from 4 to 100 micrometers in
diameter. The soma is the central part of the neuron, also known as the cell body. Protein synthesis
occurs primarily within the cell body; however, protein synthesis is not restricted to the soma (Lodish
et al., 2004;Van Minnen et al., 1997). From the soma extends one axon and several dendrites. The
1

axon is an elongated fiber which projects from the soma and is responsible for relaying and receiving
signals/information to/from other neurons. Typically, the axon transmits nerve signals away from the
soma (Conde and Caceres, 2009). Dendrites are tree-like extensions, which increase the cell surface (as
opposed to length, as is with the axon). They are responsible for signal reception from the axon termini
of neighboring neurons and transmit electrical stimuli to the soma (Conde and Caceres, 2009). Small
protrusions on the dendrites, known as dendritic spines, act as the physical contact point between
adjacent communicating neuron synapses and receive signals in the form of neurotransmitters (Sekino
et al., 2007).

Post-Synaptic Density
The post-synaptic density (PSD) is a protein and electron dense structure found beneath the postsynaptic membrane of dendritic spines (Sekino et al., 2007) (Figure 1.1). The PSD functions to
organize and concentrate the signal transduction machinery, including neurotransmitter receptors in the
synaptic cleft. This allows for the maintenance of synaptic plasticity and homeostasis (Gong and
Lippa, 2010; Ziff, 1997). More specifically, the protein PSD-95, along with the Shank family of
proteins, organizes the clustering of neurotransmitter receptors and scaffolding proteins at the PSD
(Gong and Lippa, 2010; Naisbitt et al., 1999). Many important neurotransmitter receptors are found in
the PSD such as the N-methyl D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptors, which are stimulated by glutamate. (Schlager and
Hoogenraad, 2009; Yomada and Nabeshima, 2004).

2

Active Zone
The active zone (AZ) is the site of neurotransmitter release located in the pre-synaptic nerve terminal
and is located directly across from the PSD on the receiving dendrite (Figure 1.1). This area is defined
as a specialized, dense network of actin filaments that are tightly associated with the plasma membrane
on the axon (Shapira et al., 2003). The active zone functions to meticulously regulate the timing and
positioning of neurotransmitter release. This occurs only upon receiving an action potential from a
neuron. Once the action potential is propagated along the axon and reaches the axon terminal, voltagegated calcium channels are activated and allow a local influx of calcium. This provides a signal for
vesicles containing neurotransmitters to fuse with the membrane to be subsequently released into the
synaptic cleft. Once released, the neurotransmitters diffuse across the synaptic cleft to bind to receptors
located on the post-synaptic membrane of the PSD (Garner and Shen, 2008; Shapira et al., 2003).
There are a number of multimeric protein complexes and scaffolding proteins concentrated in the AZ.
These proteins serve to fine-tune the synaptic vesicle docking, fusion and release (Shapira et al.,
2003). An example of such a complex would be members of the soluble N-ethylmalemide sensitive
factor

(NSF)

attachment

protein

receptor

(SNARE)

family;

namely,

syntaxin-1,

synaptobrevin/VAMP2 and SNAP25, which specifically promote vesicle docking and fusion (Sudhof,
2000). Syntaxin-1 and SNAP25 are transported in an 80 nm dense-core granule termed the Piccolo
Transport Vesicle (PTV). The PTV is transported to new synapses and participates in AZ assembly
(Zhai et al., 2001). Once these complexes have reached the AZ they facilitate neurotransmitter
exocytosis by bringing the synaptic vesicles in close proximity to the pre-synaptic membrane (Shapira
et al., 2003).

3

Figure 1.1 Structural organization of synapses. Schematic diagram displaying the components of
synaptogenesis. The active zone is described as the area of neurotransmitter release, whereas the postsynaptic density is the protein (receptor) and electron-dense region of the post synaptic neuron.
Synaptic vesicles house neurotransmitters that are released at the pre-synaptic terminal.
Neurotransmitters must than diffuse across the synaptic cleft to bind on membrane-associated
receptors concentrated at the post-synaptic density. Binding of ligand to receptor initiates
conformational changes and subsequent up/down stream signaling. (Cai & Sheng, 2009).

4

1.3 The Neuronal Cytoskeleton
The neuronal cytoskeleton constitutes the structural building blocks of a neuron. It is essential in
providing structural support within a neuron all the while maintaining an active and ever changing role
in allowing the cell to change in size and shape over time (Chevalier-Larsen and Holzbaur, 2006). A
coordinated and dynamic reorganization of the cytoskeleton is crucial for proper neuronal
morphogenesis (Poulain, and Sobel, 2009). The neuronal cytoskeleton consists primarily of three
different components: Microtubules (α and β), microfilaments (actin) and intermediate filaments
(neurofilaments, α-internexin and peripherin) (Chevalier-Larsen and Holzbaur, 2006).

Microtubule dynamics
Microtubules serve many fundamental cellular functions. These essential roles include but are
not limited to serving as structural components within cells, acting as the tracts for intracellular
transport of cargo and organelles and ensuring proper chromosome segregation during mitosis
(Kaverina and Straube, 2011).
Microtubules are the largest and most ubiquitous cytoskeletal structures of the neuron, and are
formed by the polymerization of α and β heterodimers (Downing and Nogales, 1998). This process is
extremely dynamic and necessary for proper outgrowth of the axon (Chevalier-Larsen, and Holzbaur,
2006). The α and β heterodimers assemble in a „head-to-tail‟ pattern, forming protofilaments that in
turn interact longitudinally to form the microtubules (Desai and Mitchison, 1997; Sun et al., 2011)
(Figure 1.2). This tandem polymerization arrangement leads to an intrinsic difference between each end
of the microtubule resulting in a polarity with β-tubulin exposed at one end (known as the plus end) and
α-tubulin exposed at the other (minus end) (Desai and Mitchison, 1997; Sun et al., 2011). This polarity
allows for molecular motors to operate in a bi-directional manner along the microtubule tracts.
Microtubule arrangement differs slightly between axon and dendrites. Microtubule orientation is more
5

uniform in the axon, with the plus ends facing the axon tip. In dendrites, however, there is a lack of
unipolarity with mixed orientation where the plus ends can face either the cell body or the dendritic tips
(Hirokawa and Takemura, 2004; Conde and Caceres, 2009).
Microtubules are highly dynamic structures allowing for frequent transitions between a
growing/elongating (polymerization) stage to a shrinking stage (de-polymerization). This is
accomplished by a shift in the reversible non-covalent association of α and β heterodimers at their ends
(Sun et al., 2011;Kirschner and Mitchison, 1986). The ability of microtubules to undergo cycles of
rapid growth and disassembly is often referred to as dynamic instability (Conde and Caceres, 2009).
These dynamic properties are crucial for many cellular functions, in particular cell division and
migration. This can of course be applied to and is thus extremely important in cortex development
where coordinated neuron migration is essential and requires dramatic cytoskeletal rearrangement (Sun
et al., 2011; Desai and Mitchison, 1997).
There also exists a more stable, less dynamic population of microtubules. These microtubules
harbor post-translational modifications such as acetylation and detyrosination. The enzyme
carboxypeptidase catalyzes microtubule detyrosination, whereas several acetyltransferases have been
associated with microtubule acetylation including ARD1– NAT1 (arrest-defective 1–amino-terminal,
αamino, acetyltransferase 1)and the elongator protein complex (ELP complex) (Janke & Bulinski,
2011; These modifications do not directly cause microtubule stabilization but instead allow for the
binding of other proteins (such as neuronal proteins MAP2 and Tau), which then confer stabilization
(Sun et al., 2011; Schulze and Kirschner, 1987; Verhey and Gaertig, 2007). As neurons age, the
microtubules found in their cytoskeletal networks are stabilized by microtubule associated proteins
which cap their ends. These proteins play an important role in regulating the structural properties of

6

microtubules and thus that of the neuron as well (Sun et al., 2011; Amos and Schlieper, 2005; EtienneManville, 2010; Simeonov et al., 2009).
It is evident that microtubules are crucial to many cellular functions. Microtubule assembly and
stabilization, as well as the dynamic changes in microtubule organization greatly contribute to
neuronal polarization and thus will be a major focus in this thesis (Conde and Caceres, 2009).

Figure 1.2 Microtubule Structure. Diagram displaying the components of a microtubule:
consisting of protofilaments of alpha and beta tubulin dimers, which interact longitudinally to
form the microtubules.
http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/C/Cytoskeleton.html
7

Actin
Actin also contributes to the dynamic nature of the neuronal cytoskeleton, as it is the filament
utilized in rapid growth located at the growth cone at the tip of elongating neurites (Cai and Sheng,
2009). Actin can exist as either monomeric (G-actin/globular actin) or in filamentous forms (F-actin).
Actin plays an important role in the elongating growth cone by allowing for the binding of proteins,
which have been shown to be critical in successful neurite guidance and extension (Pak et al., 2008).
Similar to microtubules, actin filaments also maintain polarity allowing for bi-directional transport of
molecular motors carrying cargo and organelles (Pak et al., 2008). Furthermore, the actin cytoskeleton
regulates the shape of the dendritic spines and is ultimately required for proper development of
neuronal networks (Mizui et al., 2005).

Intermediate Filaments
Neurofilaments are the primary form of intermediate filaments, and the most abundant
cytoskeletal protein, found in mature neurons (Morris and Lasek, 1982). Neurofilaments assemble
from three variable subunit polypeptides: a light, medium and heavy chain. Unlike microtubules and
actin, once assembled, these filaments lack polarity and thus dynamic properties. Neurofilaments
function primarily to provide support and stabilization for normal axonal radial growth and regulate
the diameter of myelinated axons, in turn allowing for increased conduction velocity (Perrot et al.,
2008; Cai and Sheng, 2009). Neurofilaments also differ from their other cytoskeletal counterparts in
that they do not seem to participate in molecular transport (Perrot et al., 2008).

1.4 The Importance of Molecular Transport in Neuron Function and Outgrowth
The transport of cargo (including synaptic vesicles carrying neurotransmitters) and organelles
plays an important role in synaptogenesis and subsequently the development and proper functioning of

8

the cortex. Synaptogenesis is the formation of synapses between neurons and occurs as an integration
of signaling, recognition, adhesion and protein targeting. This process begins with axonal guidance to
the correct region of the brain and is followed by neurotransmitter release opposite neighboring
neurons displaying the appropriate cluster of neurotransmitter receptors and signaling molecules (Cai
and Sheng, 2009). Transport via molecular motors is essential to this process as many synapses are
often distant from the cell soma. There are many components involved in synaptogenesis, such as
organelles (particularly mitochondria), newly synthesized synaptic proteins, synaptic vesicles carrying
neurotransmitters, receptors among others, all of which must be transported along lengthy neuronal
processes, thus conferring an important role to molecular transport in proper neuron function (Cai and
Sheng, 2009). The neurotrophin/Trk signaling cascade (described below) can be used as a prime
example. This signaling cascade is essential in promoting the survival, differentiation and growth of
neurons. Molecular transport is essential in this process, as the activated neurotrophin/Trk complexes
must be actively transported from the synapse towards the cell body in order to induce the necessary
pro-growth signals (Delcroix et al., 2003). Failed transport of such complexes has been linked to
neuronal cell death, often occurring in many neurodegenerative diseases (Campenot and MacInnis,
2004). Molecular transport is important in nearly all aspects of neuron function including neurite
outgrowth, differentiation, communication between cells as well as synapse formation and plasticity
(Delcroix et al., 2003).
Regulated molecular transport is essential not only for proper neuron function but outgrowth as
well. The microtubule and actin filaments responsible for initiating neurite outgrowth are, in fact,
initially synthesized at the cell body and must be transported towards the growing axon or dendrites to
allow for extension. Furthermore, there have also been a number of mRNAs encoding proteins such as
actin, tubulin, neurofilaments, kinesin, nuclear-encoded mitochondrial proteins and heat-shock

9

proteins (Gioio et al., 1994; Gioio et al., 2001; Kaplan et al., 1992), all of which are locally
synthesized at the tip of the axon (Van Minnen et al., 1997). The majority of mammalian axonal
mRNAs are transported from the cell body in RNA granules. The local synthesis of protein from
mRNA and the use of RNA granules as a mode of transport is due to the fact that many cytoskeletal
components such as actin and microtubules travel fairly slowly. In contrast, RNA granules have the
advantage of traveling at a much faster rate thus allowing for the cytoskeletal components to be readily
available for neurite extension and maintenance (Knowles et al., 1996; Zhang et al., 2001).

1.5 Mechanism of Molecular Transport
As previously mentioned there are two forms of tracks for molecular motors to operate along and
transport cargo and organelles. A “dual transport” model has been suggested where microtubule
filaments are involved in long range transport (along axons) and actin filaments mediate short range
transport in microtubule void areas (such as in the dendrites) (Bridgeman, 1999; Langford, 2002). Due
to the arrangement and polar nature of microtubule and actin filaments, transport is bi-directional,
occurring in both an anterograde (away from the cell body) and retrograde (towards the cell body)
manner (Cai and Sheng, 2009). There are two functional parts to any molecular motor: the motor
domain that interacts directly with the microtubule/actin filaments converting the energy of ATP
hydrolysis into movement and a tail domain that interacts with intracellular cargoes (Cai and Sheng,
2009). There are also two ways in which a molecular motor may couple with the cargo it transports:
direct or indirect. The direct method of coupling occurs when the molecular motor binds directly to the
cargo being transported. The indirect method occurs when an adapter protein mediates the binding of
the molecular motor to the cargo of interest (Cai and Sheng, 2009). There also exist two classes of
axonal transport within neurons. The first is known as fast axonal transport, occurring from 200-400
millimetres/day (mm/d). This method mediates the transport of synaptic vesicle precursors, active zone
10

precursors, mitochondria and amyloid precursor protein (APP). The second is known as slow axonal
transport, traveling only at 0.2-1 mm/d. The slower transport moves the larger subunits of the
cytoskeleton such as the actin and microtubule filaments (Brown, 2003).
Membrane and secretory proteins and lipids (as well as other secreted compounds) to be
transported must be done so within a vesicle. The creation of nascent transport vesicles is performed
by coat protein complexes that engulf and concentrate the cargo and facilitates the sculpting of the
plasma membrane (Pucadyil and Schmid, 2009). If looking at anterograde transport (toward the
synaptic terminal at the axon), cargo would then be loaded onto kinesin motors, which use the
microtubule filaments as their track upon which they move. Molecular motors hydrolyze ATP in order
to generate force to move the cargo-motor complexes to their final destination (Cai and Sheng, 2009).
When cargo reaches the synaptic terminal, the complex terminates use of the microtubule filaments
and kinesin motor and initiates the use of the actin-based molecular motor myosin (Langford, 2002).
Myosin also generates energy through the hydrolysis of ATP. Myosin is the final motor utilized in
correctly transporting cargo to the tip of the axon or dendritic spines. Transport in the reverse
direction, also known as retrograde transport, is done so by the molecular motor dynein. Myosin would
initially transport the cargo from the synaptic membrane onto the microtubule tracks, but instead of
kinesin, dynein would then facilitate long-range transport back towards the cell body (Cai and Sheng,
2009; Naisbitt et al., 2000).
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Figure 1.3 Mechanism of molecular transport. Diagram demonstrating the transport of synaptic
cargo and organelles from the cell soma to the synapse. Dynein and Kinesin are the molecular motors
involved in long-range transport along microtubules in the axon, whereas Myosin is the molecular
motor involved in short-range transport along actin filaments in the dendrites. (Cai & Sheng, 2009).
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1.6 Molecular Motors
In neurons, three classes of molecular motors are involved in axonal transport: dynein, kinesin
and myosin. All three are of equal importance in neuron function with many neurological diseases
arising from altered or mutated molecular motors (Banks and Fisher, 2008).

Dynein
Dynein exists in two forms: cytoplasmic and axonemal. Cytoplasmic dynein is the major motor
driving retrograde transport. It directs itself along the minus ends of microtubule filaments, traveling
towards the cell body (Kardon and Vale, 2009). An accessory complex, dynactin, is also required for
most dynein functions including cargo attachment and progression (King and Schroer, 2000; Karki and
Holzbaur, 1999). Axonemal dynein functions in ciliary and flagellar oscillations (Kardon and Vale,
2009). Cytoplasmic dynein is a large protein complex comprised of a heavy chain, intermediate chains
and light chains (Pfister et al., 2006). Dynein‟s core, a homodimer of heavy chain subunits, is what
allows it to progress in an ATP-dependent manner (Gennerich et al., 2007).

Kinesin
Kinesin motors drive anterograde transport along the axon. Kinesins transport cargo in the same
manner as dynein, utilizing microtubules as their tracks and ATP as the energy source (Cai and Sheng,
2009). There are a total of 15 kinesin families, which are composed of over 45 proteins (Hirokawa et
al., 2009). Depending upon the location of their motor domain, kinesin motors can be separated into
three subtypes: N-terminal kinesins (plus-end mediated transport), C-terminal kinesins (minus end
transport) and M-kinesins (responsible for depolymerizing microtubules) (Hirokawa, 1998). Kinesin-1,
the first identified motor protein (Vale et al., 1985; Hirokawa et al., 1991) has a heavy chain consisting
of three similar subtypes: KIF5A, KIF5B and KIF5C. KIF5B happens to be ubiquitously expressed,
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whereas KIF5A and KIF5C are enriched in neurons (Kanai et al., 2000). There exist two forms of
KIF5 motor-cargo coupling due to the presence of both heavy and light chains. The KIF5 motors tend
to form either homo or heterodimers amongst themselves. Although KIF5 itself possesses the motor
function, it can also bind to the light chain of Kinesin-1; therefore KIF5 association with its cargo can
either be mediated directly through its tail domain or indirectly through the carboxy-terminal domain
of its light chain (Hirokawa and Noda, 2008; Cai and Sheng, 2009). As is the case with dynein,
kinesins also transport a variety of proteins and organelles; subsequently they help regulate processes
such as neurite outgrowth and neuron polarization (Hirokawa et al., 2009). Specifically, KIF5B has
been shown to transport syntaxin-1 positive vesicles in neurons (Su et al., 2004).

Myosin
Unlike dynein and kinesin, the myosin family of motor proteins mediates short-range transport,
using actin instead of microtubules as their tracks upon which they travel (Cai and Sheng, 2009;
Langford, 2002). Myosin motors are composed of three distinct functional domains: the motor domain,
which interacts with actin, binds and hydrolyzes ATP; the neck domain, which binds to light chains;
and finally the tail domain which has the purpose of anchoring the entire myosin complex to the actin
filaments (Sellers, 2000). Although there exist over 15 different classes of myosins, only a few have
been linked to neuronal transport. These include myosins X, V and II. Myosin X is known to localize
to the tips of filipodia in both neuronal and non-neuronal cells (Sousa et al., 2006). Myosin V has been
known to associate with neurofilament subunits, synaptic vesicles, endoplasmic reticulum, secretory
granules and other axonal vesicles suggesting a role in neurotransmission; although it remains unclear
the role, if any, myosin plays in regulating and remodeling synapses in response to neuronal activity
(Bridgman, 2004). Finally, myosin II is well known for its role in growth cone extension and
neurotransmitter release (Sellers, 2000; Vallee et al., 2009). Myosin II is localized at the pre-synaptic
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terminal where it regulates neurotransmitter release by facilitating synaptic vesicle transport to the
active zone (AZ).

1.7 Cortical Neurogenesis
The cerebral cortex is an eminently organized brain structure consisting of immensely diverse
neuron subtypes. It is this neuronal diversity that forms the foundation of cortical function and
underlies its most sophisticated tasks (Tiberi et al., 2012). Cortical neurons can generally be divided
into two classes: excitatory pyramidal/projection neurons and the inhibitory interneurons. Pyramidal
neurons constitute the majority (approximately 85%) of neurons found in the cortex and can be further
categorized into several subtypes; each subtype is characterized by specific morphology,
electrophysiology and connectivity (Molyneaux et al., 2007). Cortical neurons are meticulously
organized into specific areas and layers, which in turn predict their particular functions and properties
(Tiberi et al., 2012).

Each area of the cortex consists of a distinct subset of neurons that are

specialized in particular functions, such as visual or motor areas. Furthermore, each area is then
divided into six functionally unique layers distinguished from one another by the different subtypes of
neurons that occupy them. Each subtype of neuron is characterized by specific patterns of axonal input
and output (O‟Leary and Nakagawa, 2002; Sur and Rubenstein, 2005; Rash and Grove, 2006; Tiberi et
al., 2012).
As the cerebral cortex is such a complex and highly ordered brain structure it is understandable
that there are many components involved in its development, each of which is inherently essential for
proper brain development. Cortical development requires precise timing and coordination of neuronal
and glial progenitor cell proliferation as well as their ensuing migration in response to a variety of
internal and external cues (Campbell, 2005; Tiberi et al., 2012). The generation of cortical neurons
relies initially on dividing progenitor cells, which then leave the cell cycle, and differentiate into
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newborn neurons, and then migrate to their appropriate laminar locations (Creppe et al., 2009). Once
stably positioned, they complete differentiation upon which they begin to actively extend out neurites.
All of these steps require the remodeling of the cell and thus largely depends on the regulation of the
cell cytoskeletal components (Creppe et al., 2009).
Cortical neurogenesis begins at embryonic day 10 (E10) in the mouse with neural stem cells and
intermediate progenitor (IPCs) cells located in the ventricular zone (VZ) and subventricular zone
(SVZ) respectively (Shen et al., 2006). The first type of cells to emerge is the neuroepithelial (NE)
progenitor, which undergoes symmetric proliferative divisions in order to expand the pool of cortical
progenitors (Tiberi et al., 2012). NE progenitors located in the VZ eventually convert to radial glial
(RG) progenitors (at the onset of neurogenesis), which comprises the major subtype of cortical
progenitors. RG progenitors undergo both symmetrical and asymmetrical divisions; this allows for the
generation of a diverse set of neurons as well as the maintenance of the progenitor cell pool.
Symmetrical division generates two identical radial glial cells whereas asymmetrical division can
generates a radial glial cell and either one IPC or a newly identified class of radial glia-like (oRG)
progenitor cell, the latter of which will subsequently divide symmetrically to produce two neurons
(Wang, X. et al., 2011).There are a number of other types of progenitor cells, including the IPCs. IP
cells do not maintain stem cell-like properties like their RG counterparts as they will only divide
symmetrically one or twice before generating neurons (Tiberi et al., 2012). As cells exit the cell cycle
they must migrate away from the ventricles into the developing cortex to occupy six precise laminar
locations. Migration is facilitated by the neuronal processes (microtubules), which are generated by the
RG cells (Wang, X et al., 2011). Movement along these microtubule tracts is dependent upon both
MAPs as well as molecular motors. The MAPs function to change microtubule stability by regulating
the extension and retraction, while the molecular motors function to physically transport the neuronal
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cell body along the radial process to its final destination. The preplate cells, which are the first set of
neurons, arise from the VZ and eventually give rise to subplate neurons (a transient population of cells
occupying the base of the cortical plate) and neurons located in the marginal zone (first layer) (Shen et
al., 2006). As development proceeds, each set of newer born neurons must migrate past the previous
set of neurons into a more superficial layer. Essentially, this occurs in an „inside-out manner‟, with the
newest born neurons located at the very top of the cortical plate (Rice and Curran, 2001). Once
migration has terminated and neurons are stably located in the proper layer, differentiation is
completed upon the extension of axonal and dendritic projections (Shen et al., 2012). The regulation
between proliferation and differentiation can be attributed to several families of morphogenic factors,
including the fibroblast growth factors (FGF‟s), as discussed below (Sahara and O‟Leary, 2009; Kang
et al., 2009).

1.8 Neurotrophins and Receptor Tyrosine Kinases Impact Neuronal Growth, Differentiation and
Survival
An important component essential to proper brain development includes many growth factors
and the downstream signaling that they propagate. The neurotrophic growth factors, which activate the
tropomyosin related kinase (Trk) family of receptor tyrosine kinases, are an excellent example. They
have been described as being critical to neuronal survival, development and differentiation as well as
function, including synapse formation and plasticity (Reichardt, 2006). There are four primary
neurotrophins in the mammalian nervous system: nerve growth factor (NGF), brain derived
neurotrophic factor (BDNF), neurotrophin 3 (NT-3) and neurotropin 4 (NT-4); all of which act upon
the Trk family of receptor tyrosine kinases to initiate downstream signaling cascades (Delcroix et al.,
2003). There also exists the p75 neurotrophin receptor (p75NTR), to which each mature neurotrophin
can bind with low affinity (Bibel and Barde, 2000). This receptor has been shown to be involved in
17

cell survival as well as cell death depending upon the physiological state of the cell (Hamanoue et al.,
1999; Aloyz et al., 1998). The Trk family of receptor tyrosine kinases and neurotrophins, in unison,
has been established to be involved in nearly all aspects of neuronal development and functioning.
Activated neurotrophin/Trk complexes are able to induce physiological changes once they are
transported as signaling endosomes from the synapse back to the cell body; here they can modulate
cellular gene expression and function (Delcroix et al., 2003).

1.9 Neurotrophins and Trk signaling
In terms of structure, each neurotrophin protein consists of a signal sequence and a pro-domain,
which, once cleaved, is followed by the mature neurotrophin final product. To exemplify: NGF has its
signal sequence cleaved within the endoplasmic reticulum resulting in a proNGF molecule (Buttigieg
et al., 2007). ProNGF may then be cleaved either intracellularly (by proteases) or extracellularly (via
plasmin) to produce the mature, functional, 13 kDa form of NGF (Seidah et al., 1996; Bruno and
Cuello, 2006). While the majority of neurotrophins found in the brain are secreted in their pro form, it
is the mature form that displays most functionality as it can act upon and bind with high affinity to the
Trk receptors to induce growth signals in neurons (Bruno and Cuello, 2006).
There are three members in the Trk receptor family in mammals, each of which is activated by
their own set of neurotrophins: TrkA (activated by NGF or NT-3), TrkB (activated by BDNF) and
TrkC (activated by NT-3 or NT-4/5) (Reichardt, 2006). Each Trk receptor has an extracellular domain
composed of a cysteine-rich cluster, three leucine-rich repeats and two immunoglobulin-like domains.
Each receptor spans the membrane once with a cytoplasmic domain at the terminal end, which consists
of a tyrosine kinase domain containing multiple tyrosines. These tyrosines, when phosphorylated, can
act as docking sites for signaling proteins that, once bound, can propagate downstream signaling.
Binding of any ligand to its Trk receptor induces dimerization of the receptor monomers followed by
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trans-phosphorylation of salient tyrosines which act to both stabilize the receptor in its
conformationally active form as well as act as a docking sites for adapter proteins that are to propagate
the signaling cascade to the appropriate target proteins (Huang and Reichardt, 2003; Skaper, 2008).

1.10 FGF Signaling & FRS3
The FGFs are a large family of growth factors that act as powerful morphogens influencing the
development of multiple tissues, including the nervous system (Yamaguchi and Rossant, 1995; Cayuso
and Marti, 2005). Defects in FGF signaling have resulted in experimental models with altered cortical
structure, thus attributing an important role to FGF signaling in cortical development. Many of the
FGFs are responsible for regulating the balance between proliferation and differentiation, which is
crucial for proper cortex development. Moreover, FGF2 in particular has been described to be essential
for the proliferation and differentiation of neural stem cells in the VZ and SVZ (Vaccarino et al.,
1999). FGFs bind to receptor tyrosine kinases resulting in their dimerization, activation and subsequent
phosphorylation at specific residues. These phosphorylated residues then serve as docking sites for
adapter proteins in order to mediate intracellular signaling. The FGF receptor substrate (FRS) family
of adaptors is a primary intracellular adaptor of the FGF receptors. This family consists of two
proteins, FRS2 & FRS3; both of which share similar structures including an N-terminal myristoylation
signal sequence, followed by a phosphotyrosine-binding (PTB) domain. In addition, both proteins
contain tyrosine residues that can be phosphorylated and act as binding sites for Grb2 and Shp2. These
phosphotyrosine docking sites function to activate phosphatidylinositol 3‟OH kinase (PI3 OH) and
prolonged Ras/Erk signaling. Based on these similarities, it has been suggested that FRS2 and FRS3
serve functionally redundant roles during development; however, there has been a growing body of
evidence, both structural and functional, suggesting otherwise. Recent studies suggests a distinctly
separate role for FRS3 aside from its role in FGF signaling, which shall be discussed further below.
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Figure 1.4 FGF signaling. Schematic diagram representing FGF signaling with Trk receptors.
Binding of FGF ligand to receptor tyrosine kinases induces receptor dimerization, activation and
subsequent phosphorylation at specific residues which then serve as docking sites for adapter proteins
which mediate intracellular signaling (including FRS2 and FRS3). (Diagram courtesy of Alfonso
Dietrich, Msc Biochemistry, UWO).

20

1.11 Differing Properties of FRS2 & FRS3
With the use of in situ hybridization, FRS2 and FRS3 have been shown to have distinct
expression patterns within the developing embryo. FRS2 is ubiquitously expressed whereas FRS3 is
primarily restricted to the nervous system (McDougall et al., 2001; Gotoh et al., 2004). Structurally,
the two proteins only share 48% sequence identity, which is primarily restricted to the PTB domain
and C-terminal tail (Zou, et al., 2003). This is highly suggestive that both adapters couple receptors to
separate pathways. Both adaptors also display varying binding properties; as an example, binding to
TrkA is not affected with the deletion of 5 residues N-terminal to pTyr499 with FRS3 as is observed
with FRS2 (Dixon et al., 2006). Furthermore, both proteins act differently in culture in many ways.
For example, when FRS3 is overexpressed in PC12 cells there is no observed increase in NGF-induced
neuronal differentiation, while FRS2 is required to facilitate this process (Zeng and Meakin, 2002). In
addition, both proteins have different sub-cellular distributions. Despite them both having
myristoylation signal sequences that promote tight association with the cell membrane in transfected
cells, FRS3 directly isolated from brain is primarily cystolic (Hryciw et al., 2010). By comparison
FRS2 is primarily associated with lipid rafts, which is to be expected (Ridyard and Robbins, 2003;
Bryant et al., 2009). It could be speculated that the myristoylation signal sequence is cleaved in vivo at
some point, accounting for FRS3 being found in the cystolic fraction upon direct isolation from the
brain. Finally, FRS3 has been shown to bind microtubules and co-immunoprecipitate (co-IP) with
various molecular motors, while FRS2 does not (discussed in further detail below) (Hryciw et al.,
2010). This last point brings about the possibility that FRS3 may link neurogenic receptors to the
regulation of microtubule dynamics and cargo transport, events that are crucial during the development
of the cortex.
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1.12 Preliminary Evidence supporting a role for FRS3 in cortical neurogenesis
The differing properties discovered between FRS2 and FRS3 warranted further investigation into
additional roles for FRS3 within the brain. The non-overlapping patterns of FRS3/FRS2 expression
were discovered through various in situ hybridization, RT-PCR, and immunohistochemistry
experiments (Hryciw et al., 2010). These results further supported a role for FRS3, not FRS2, within
brain tissues as FRS2 displayed a uniform expression, whereas FRS3 expression was mostly restricted
to neural tissues (Hryciw et al., 2010; McDougall, K. et al 2001; Gotoh, N. et al 2004). Given the
abundant expression of FRS3 within the brain, the next step was to investigate FRS3 and its
endogenous pattern of expression during cortical development. FRS3 expression is detectable as early
as E12, and coincides with the expression of β III tubulin, a neuron specific protein. Furthermore,
FRS3 was also discovered to be a neuron-specific protein, as it was not detected in astrocyte cultures
(Hryciw et al., 2010). Levels of both proteins begin to rise after E12, until the first post-natal week
(P1-P7) upon which they eventually decline slightly and level off during adulthood (Hryciw et al.,
2010). Given the previous expression patterns, immunohistochemistry (IHC) was used to determine
which cells expressed FRS3 as well as its subcellular localization. Sections from developing E12
cerebral cortex were used where FRS3 showed very weak co-localization with Nestin (marker of
proliferating stem cells); but strong co-localization with acetylated α-tubulin (marker of migrating
neurons) as well as β III tubulin (marker of post-mitotic neurons) at the cortical plate (Hryciw et al.,
2010). This suggests that FRS3 expression initiates with the birth of cortical neurons and coincides
with their migration in the developing cortex. Further supporting this notion is FRS3‟s presence in two
different cell populations, the proliferative zone as well as the cortical plate (Hryciw et al., 2010).
As FRS3 displayed nearly identical staining patterns throughout the neuron as β III tubulin and
acetylated α-tubulin, this led to the hypothesis that FRS3 interacts with cytoskeletal components.
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To this end, a microtubule reconstitution assay was completed showing FRS3 but not FRS2 to be a
microtubule-associated protein (Hryciw et al., 2010). Finally, a number of co-immunoprecipitations
were completed in order to deduce some of the binding partners of FRS3. Consistent with the IHC,
FRS3 was found to interact with both acetylated α-tubulin and β III tubulin. Furthermore, FRS3 was
found to co-precipitate with MAP2 (a microtubule-associated protein involved in stability) as well as
with the Kinesin Heavy Chain, one of the molecular motors described above (Li, unpublished).
Collectively, this suggests that FRS3 may be involved in a) providing microtubule stability during the
migration of newborn neurons and b) microtubule stability/microtubule-based transport in post-mitotic
neurons.

Hypothesis
FRS3 regulates neuron maturation as well as post-mitotic neuron function, by regulating microtubule
stability and/or the intracellular transport of cargo and organelles.

Objectives
AIM 1: Investigate the MT binding properties of FRS3 and its interactions with various proteins
involved in molecular transport within cortical and hippocampal neurons; (including motors, adapters
and cargo).
AIM 2: Characterize the role of FRS3 in cortex development by investigating FRS3‟s interaction with
microtubules and potential role in providing stability, thus gaining insight into FRS3‟s role in brain
development
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Chapter 2: Methods and Materials:
2.1 Cell Cultures:
*NOTE: All work done with cell cultures were conducted under a HEPA-filtered biological cabinet.
2.1.1 HEK 293T Cells:
Human Embryonic Kidney 293 T cells were cultured in DMEM supplemented with 10% FBS
and 50 ug/mL of gentamycin sulfate and incubated at 37C and 5% CO2. Cells were split twice a week
upon reaching 80% confluency.
2.1.2 SN56 Cells:
SN56 cells are derived from the fusion of cholinergic septal neurons with a septal neuroblastoma
cell line and thus they retain cholinergic properties (Hettiarachi et al., 2010). Upon treatment with
dibutrylcyclicAMP (dbcAMP) (0.5 mg/mL) for 24 hours, SN56 cells display a neuronal morphology
and have the ability to extend neurites (Hammond et al., 1986; Lorenzen et al., 2010). Consequently,
SN56 cells have served as an excellent replacement for neurons in certain experiments, particularly in
this thesis as they do express FRS2 & FRS3 endogenously. SN56 cells were cultured in DMEM
(without sodium pyruvate) supplemented with 10% FBS and 50 μg/mL of gentamycin. Cells were
incubated at 37 C and 5% CO2. When necessary, cells were differentiated with dbcAMP at a
concentration of 500 μg/mL for 24 hours before lysing.
2.1.3 E15 Cortical Neurons
Embryonic day 15 mice were used for primary cortical neuron cultures. Pregnant female CD-1
mice were euthanized in a CO2 chamber according to S.O.P. #320-02 from the University of Western
Ontario

(www.uwo.ca/animal/website/VS/Content/SOPs/320Euth.pdf).

Following

euthanization,

embryos were dissected into a 10 cm petri dish containing 30 mL cold HBSS on ice. Each embryo was
individually moved to a new 10 cm petri dish containing 10 mL cold HBSS. The cortical hemispheres
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were dissected out, olfactory bulbs and meninges were removed. Cortical hemispheres were then
transferred to a new 60 mm dish containing 5 mL cold HBSS on ice. Cortices were minced with a
razor blade and transferred to a 15 mL conical tube using a plastic pipette. Once cortices had settled to
the bottom of the tube, HBSS was removed. Cortices were triturated in 2 mL fresh neurobasal 10 times
with a 1mL micropipette using the standard tip. Cortices were left to settle to the bottom of the tube
and the supernatant was removed and transferred to a new 15 mL conical tube. Another mL of
neurobasal was added to the original tube and the cortices were triturated once more as previously
described. Both sets of supernatants were pooled together and filtered through a 70 μm mesh (BD
Falcon). This solution was made up to 9 mL with neurobasal media and an additional 1mL of FBS was
also added. This was spun at 800 rpm for 5 minutes (Beckman Coulter-Allegra X-22R Centrifuge).
The media was aspirated off carefully, so as not to disturb the pellet, and cells were re-suspended in 10
mL of neurobasal media. Cells were counted using a hemocytometer. Approximately 10 million cells
were plated per 10 cm dish (previously coated with 0.5 mg/mL poly-D-lysine a minimum of one hour
prior to plating). If cells did not look healthy the next day, media was replaced with 10 mL fresh
neurobasal maintenance media.
2.1.4 E18 Hippocampal Neurons
Embryonic day 18 mice were used for primary hippocampal neuron cultures. The protocol was
adapted from Kaech & Banker, 2006. Pregnant female CD-1 mice were euthanized in a CO2 chamber
according

to

S.O.P.

#320-02

from

the

University

of

Western

Ontario

(www.uwo.ca/animal/website/VS/Content/SOPs/320Euth.pdf). Following euthanization, embryos
were released from the germinal sacs and decapitated. Each brain was removed and placed into a 10
cm petri dish containing cold HBSS on ice. Each brain was then individually placed into a new 10 cm
petri dish containing cold HBSS where it was dissected under a microscope, while the remaining
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brains stayed in HBSS on ice. The meninges were removed from each brain and then the hippocampus
was carefully dissected, removed and placed into a 60 mm petri dish containing 5 mL HBSS on ice.
Once all hippocampi had been removed and placed in HBSS, this mixture was transferred to a 15 mL
conical tube. The hippocampi were incubated with 500 uL of 2.5% Trypsin at 37C for 15 minutes.
Following digestion, the mixture was topped up to 10 mL with more HBSS and an appropriate amount
of 1% DNAse (until the clump of tissue dissociated) was added; the tube was inverted 2-3 times to
facilitate DNA digestion. Once the hippocampi had settled to the bottom of the tube, the media was
removed with a plastic pipette and 10 mL of fresh HBSS was added. This was repeated 3 times in total
to wash any residual trypsin from the tissue. Following washing, the tissue was triturated 10 times with
a regular sized Pasteur pipette, then another 10 times with a reduced diameter flame blown Pasteur
pipette. It is important to note that the diameter of the second Pasteur pipette was always to be exactly
half that of the original pipette. Cells were then counted using a hemocytometer. Approximately 1 000
000 cells were plated onto 35 mm confocal dishes (MatTek Corp.) that were pre-incubated and coated
with 0.5 mg/mL poly-D-lysine a minimum of one hour prior to plating. Cells were initially plated in
HEK media and left to recover overnight. The next day, media was replaced with neurobasal
maintenance media. Every 3 days, half of the maintenance media was aspirated off and replaced with
fresh media until experimentation.
2.2 Fixing and Staining Neurons
Once neurons were in a healthy state with visible, long neurites (usually around 7DIV), neurons
were fixed and stained as follows: 500 μL of goat serum was added to 4.5 mL 4% paraformaldehyde.
Media was aspirated off all confocal dishes and each dish was washed once with room temperature 1x
PBS. Next, 1 mL of paraformaldehyde was added to each dish and this was left at room temperature
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for 15 minutes exactly. Dishes were washed 3 times for 10 minutes each time with 1x PBS on a belly
dancer at room temperature.
For staining, 2 mL of blocking buffer 1 was added to each dish and placed on a belly dancer for
2 hours at room temperature. Fresh blocking buffer was made and 1 mL was added to each dish with
the appropriate quantities of desired antibodies (refer to Table 1). Dishes were incubated overnight on
a belly dancer at 4C. The next day, dishes were washed 3 times with 2 mL 1x TBS on a belly dancer
at room temperature and then washed once more overnight at 4 C to eliminate any non-specific
staining. The following morning, a solution made up of 80% 1x TBS and 20% blocking buffer 1 was
made and separated into 1 mL aliquots. Appropriate secondary antibodies were added to each aliquot
(to a dilution of 1:500) and each dish was incubated with secondary antibody (refer to Table 1 for
dilutions) for 45 minutes (wrapped in tin foil from this point forward) at room temperature on a belly
dancer. Dishes were then washed 3 times at room temperature with 1 x TBS and again over night at
4C. The following day, dishes were quickly washed with distilled water to remove any salts and a
drop of DAPI (nuclear stain; Invitrogen) was applied to the center glass portion of the confocal dish, to
which a small circular microscope cover slip (Fisher Brand, 12mm) was applied. Dishes were stored at
4C wrapped in tin foil to be visualized under a confocal microscope.
2.3 Tissue Harvesting/Cell lysate preparation
Brains were harvested from mice (of various ages) that were euthanized by CO2 according to
S.O.P. #320-02. Tissues were then lysed in NP-40 lysis buffer containing the following inhibitors on
ice: 1 mM sodium orthovanadate (Sigma-Aldrich), 1 m PMSF (Sigma-Aldrich), 10 μg/mL aprotinin
and 10 μg/mL leupeptin (Bioshop). Tissues were either lysed using an electric homogenizer, glass
homogenizer or an 18 gauge needle. Samples were centrifuged at 14 000 RPM at 4C for 15 minutes
(Eppendorf Centrifuge 5417R). This facilitated organelle and cytoskeleton sedimentation.
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Supernatants were kept and subjected to a protein concentration determination assay and stored at 20C for further experimentation.
2.4 Protein Concentration Determination
Samples were assayed with the use of the BioRad (Hercules, CA) Protein Dc Assay Kit in
conjunction with the BioRad iMark Microplate Reader. This assay is based on the Lowry protein
determination assay (Lowry et al., 1951). A standard curve is obtained using known concentrations of
BSA in NP-40 lysis buffer (0 to 1.5 mg BSA is the range used). Each sample of BSA was loaded in
duplicate (5 μL) onto a 96 well microplate. Unknown samples were followed and also loaded in
duplicate in varying quantities (1 μL, 2 μL and 2.5 μL). Samples were mixed with 25 μL of solution A,
followed by 200 μL of solution B. The microplate was then placed on a shaker at room temperature for
15 minutes. The protein concentrations were then obtained using the BioRad iMark Microplate reader
at an absorbance of 655 nm.
2.5 Nocodazole Treatment
SN56 cells were plated on 10 cm culture dishes and allowed to grow to 75% confluency. Once
proper confluency had been reached, each plate was transfected with Lipofectamine 2000 (as described
below) with either a control shRNA or FRS3 shRNA. Cells were left in the 37C incubator for 24
hours to allow for proper plasmid expression. Cells were then differentiated with the addition of serum
free media and dbcAMP (0.5 mg/mL); 24 hours was allotted for proper differentiation and neurite
extension. Once cells were differentiated and had developed neuronal-like morphology, varying (300
nM-700 nM) concentrations of nocodazole (Sigma Aldrich) were added to each dish and dishes were
incubated at 37C for 2 hours. Nocodazole directly affects the cytoskeleton of cells by interfering with
the polymerization of microtubules. Next, dishes were washed twice at 37C with 1 mL Buffer A.
Cultures were then incubated for 5 minutes at 37C in 500 L of free tubulin extraction buffer (with
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protease inhibitors). Extracts were centrifuged at 37C for 2 minutes at 16 000 g (TLA-120 rotor;
Beckman Coulter-Optima TLX Ultracentrifuge). The supernatant fractions contained free tubulin
extracted from the cytosol, whereas the pellet fraction contained the polymerized microtubules. The
pellet fraction was dissolved in 500 μL of 25 mM Tris pH 6.8 with 0.5% SDS. Samples were then
resolved on a 10% polyacrylamide gel and analyzed by western blot for the presence of tubulin.
2.6 DNA Cloning, Digestion and Ligation
The shRNA construct builder from http://www.genscript.com was used to build 4 separate
shRNA inserts (refer to Figure 1 for sequences) targeted at mouse FRS3. Each shRNA had 2 oligos
with cither a BamHI or HindIII site appended to allow for directional cloning into the pRNATU6.3/Hygro vector (Genscript) (refer to Figure1 for vector map).
Annealing of Oligos
Oligos (Sigma Aldrich, refer to Figure 1 for sequences) were diluted to 1μg/mL with 5 mM
Tris-Cl elution buffer. In a small PCR tube, 1μL of the top strand was mixed with 1 μL of the bottom
strand along with 1 μL 20x SSC and 17 μL dH2O. This was put in the thermocycler at 95C for 10
minutes then left at room temperature for one hour. While this was occurring, 30 μL of the digested
pRNAT vector was run on a 1% agarose gel to purify.
Restriction Enzyme Digestion
In a 1.5 mL centrifuge tube, 1 μL of either shRNA insert or vector was mixed along with 6 μL
Buffer 10x Tango, 0.5 μL HindIII, 0.5 μL BamHI and 22 μL dH2O. Mixture was left in the 37C water
bath overnight to ensure digestion goes to completion.
DNA Gel Extraction/Nucleospin Extract kit II
The agarose gel was visualized under a UV light box where the band containing the vector DNA
was cut out, placed in a centrifuge tube and weighed. The DNA was purified from the agarose gel
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using the Nucleospin Extract Kit II (Qiagen) as follows: To the DNA, 2x w/v of NT buffer was added
and put into a 50C water bath until the gel band had dissolved (vortexing intermittently). DNA
sample was transferred to a nucleospin extract column and centrifuged for one minute at 3600 RPM
(tabletop centrifuge) at room temperature. The supernatant was removed and to it, 600 μL buffer NT3
was added and centrifuged for one minute. This was repeated for a total of two times. The supernatant
was removed and spun once again for an extra 2 minutes. The spin column was then transferred to a
clean 1.5 mL centrifuge tube; 50 μL of elution buffer (5 mM Tris-HCl) was added and left sitting at
room temperature for 30 minutes. Solution was spun for one minute to collect purified DNA.
DNA Ligation
In order to ligate the compatible ends of the shRNAs with that of the vector, the following was
mixed in a 1.5 mL centrifuge tube: 1 μL vector, 3 μL shRNA, 1.5 μL 10 mM ATP, 1.5 μL Ligation
buffer, 7.5 μL dH2O and 0.5 μL T4 DNA Ligase. The reaction was allowed to proceed at 4C
overnight. A control ligation was also set up, using H2O in place of the insert DNA. The next day, all
ligations were transformed into XL-10 Gold strain of E. coli as described below. Individual colonies
were selected, DNA extracted and sequences verified as previously described below.
2.7 Bacterial Transformation
Five μL of DNA was mixed with 150 μL of competent XL-10 Gold cells in a 1.5 mL eppendorf
tube and incubated on ice for 30 minutes. Following incubation on ice, transformations were given a
45 second heat shock in a 42C water bath and then placed immediately on ice. For recovery of cells, 1
mL of LB media was added to the transformation and the tubes were placed at 37C with constant
agitation for one hour. Transformations were then centrifuged for one minute at 4000 rpm (tabletop
centrifuge) at room temperature in order to pellet out the cells. The supernatant was removed, with the
exception of 100 μL. The pellet was re-suspended in the remaining 100 μL of LB and plated on LB
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agar plates with the appropriate selection pressure (100 μg/mL ampicillin or kanamycin) and incubated
overnight at 37C. Individual colonies were selected the next day for further experimentation (e.g.
small scale DNA preparation).
2.8 DNA extraction and purification (Mini and Maxi prep)
Bacteria containing vectors of interest were grown overnight in either 3 mL or 50 mL LB media
with 100 μg/mL Ampicillin or Kanamycin for appropriate selection pressure.
Small Scale/Mini DNA Prep:
For small-scale DNA extraction, 24 hours after LB incubation, cells were spun down at 4800
RPM at room temperature for 5 minutes in order to pellet the cells. The pellets were placed on ice and
re-suspended in 100 μL of Lysis Solution I. Two hundred μL of Lysis Solution II was also added
mixed by inverting 5 times. Finally, 175 μL of Lysis Solution III was added and inverted 5 more times
to ensure proper mixing. Samples were spun down at 13 000 RPM (tabletop centrifuge, Eppendorf
centrifuge 5415D) at room temperature for 10 minutes. Supernatant were removed and kept, pellets
were discarded. Supernatants were extracted with 500 μL Phenol:Chloroform (Bioshop) , vortexed and
centrifuged again for 10 minutes in order to allow for separation of aqueous and organic phases. The
upper phase was again extracted and kept and washed with 500 μL 24:1 Choloform:Isoamyl alcohol
and centrifuged once more as above. The upper phase was removed and mixed with 280 μL isopropyl
alcohol and allowed to sit for 30 min at room temperature (this allows for precipitation of DNA).
Samples were then centrifuged for 10 minutes. Pellets were washed twice with 1 mL 70% ethanol and
twice with 1 mL absolute ethanol. Pellets were allowed to dry and were then re-suspended in 50 μL TE
with 0.1 mM EDTA. If samples were to be later sent for sequencing, 1 μL of RNAse A was also added
and samples were incubated in a 37C water bath overnight. The following day, 150 μL H2O and 200
μL Phenol;Chloroform were added to each sample. Samples were vortexed and centrifuged at 13 000
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RPM for 10 minutes. The upper phase was extracted and washed with 200 μL Choloroform: Isoamyl
alcohol as previously described. Twenty uL of 3M sodium acetate and 450 μL of absolute ethanol was
then added to each sample which was then incubated at -80C for 30 minutes. Samples were
centrifuged and DNA pellets were washed as described above and allowed to dry. Once dry, pellets
were re-suspended in 25 μL 10 mM Tris-Cl pH 8.0. Five μL of each sample was run on an agarose gel
to verify purity and approximate concentration.
For large-scale DNA extraction (50 mL), bacterial cultures (upon 24 hour incubation) were first
transferred to a 50 mL conical tube and spun down at 4500 RPM (Beckman Coulter-Allegra X-22R
centrifuge) for 15 minutes at 4C. Pellets were placed on ice and re-suspended in 10 mL of Lysis
Solution I with the use of an 18 gauge needle. Next, 10 mL of Lysis Solution II was added and samples
were inverted several times to ensure proper mixing. Accordingly, 5 mL of Lysis Solution III was
added and mixed in the same fashion. Next, 10 mL Phenol:Chloroform (Bioshop) was added and
samples were vortexed until opaque. Samples were centrifuged at 4500 RPM (Beckman CoulterAllegra X-22R centrifugre) for 15 minutes in order to separate aqueous and organic phases. The upper,
aqueous phase was extracted and transferred to a new tube and DNA was precipitated with the addition
of 15 mL of isopropanol. Precipitated DNA was visualized in the form of stringy white cotton-like
substance and was subsequently centrifuged at 4500 RPM for 15 minutes to pellet DNA. Pellets were
allowed to dry and then re-suspended in 1 mL TE. Exactly 1.08g cesium chloride was measured out
into 1.5 mL Eppendorf tubes and dissolved in the DNA:TE mixture. Twenty μL of Ethidium Bromide
(20 mg/mL) was added in order to allow for DNA visualization. Samples were quickly spun for 3 min
at 14 000 RPM to remove any residual protein which appeared as very dark chunks floating at the top
of the sample. Next, each sample was transferred to plastic ultracentrifuge tubes (1.2 mL,Beckman
361082) and sealed using a heated tube topper, all the while checking for air bubbles and leaks. Tubes
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were placed in the Beckman TLN120 rotor and centrifuged 115 000 RPM for 1.5 hours. The cesium
chloride forms a gradient with the circular plasmid DNA in the form of a large pink band in the center
of the gradient. This pink band is then carefully extracted using a syringe and transferred to a fresh 1.5
mL Eppendorf tube. Ethidium Bromide was removed by washing with an equal volume of H2Osaturated butanol and centrifuged at 14 000 RPM for 3 minutes. DNA was found in the aqueous phase
while the Ethidium Bromide went into the butanol-rich phase (which is the less dense, upper phase).
The upper phase was removed and the DNA was repeatedly washed in the same manner until both top
and bottom phases appeared clear. DNA was re-precipitated in 2.5 volumes of 70% isopropanol at
room temperature. Samples were then washed once with 70% ethanol and once more with absolute
ethanol. DNA pellets were allowed to dry and then re-suspended in an appropriate amount (depending
on yield, usually ~200 μL) of TE. DNA quality and concentration were assessed through the use of
spectrophotometry using a Nano Drop spectrophotometer (Thermo Scientific) available in the Cregan
Lab.
2.9 Sequencing
DNA was made up to a concentration of 100 ng/mL and mixed with 5 μL of the appropriate
sequencing primer was sent to the Robarts Sequencing Facility on the 4th floor. Electropherograms
were obtained and later analyzed.
2.10 Lipofectamine Transfection
For E18 hippocampal cultures, cells were transfected 24 hours after plating with siRNAs as
follows : in an RNAse free Eppendorf tube 1 μL of Lipofectamine 2000 (Invitrogen) was added to 50
μL of OptiMEM (Invitrogen). In a separate Eppendorf tube, 20 pmol of either control Cy3 tagged
scrambled control siRNA (Ambion AM4621), FRS3 siRNA (Invitrogen/Ambion s99029,targets exon
6 starting at nucleotide 775:
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Sense:

GAGUCUACCCACACCCUCAtt

Antisense: UGAGGGUGUGGGUAGACUCtt )
Or FRS2 siRNA (Invitrogen, Catalogue # 7093296:
Sense:

CUGGCUAUGACAGUGAUGAACGAAG

Antisense: CUUCGUUCAUCACUGUCAUAGCCAG
was added to 50 μL of OptiMEM. Each mixture was pipetted up and down several times to ensure
proper mixing and allowed to sit for 5 minutes at room temperature. The contents of each Eppendorf
tube were then mixed together and allowed to sit for an additional 20 minutes at room temperature.
The transfection mixture was then carefully added drop wise to each well and incubated at 37C for 48
hours to allow proper expression. Cells were then fixed with 4% paraformaldehyde and analyzed.
For SN56/ HEK 293T cells, cells were plated on 10 cm dishes and allowed to reach 70-80%
confluency before transfection. Cells were transfected in an identical matter as described above but
with DNA instead of RNA. Instead, the total volume of OptiMEM used was 1 mL, 30 μL
Lipofectamine and 24 μg DNA.
2.11 Immunoprecipitation
GammaBind Sepharose (GE Health Care) was washed three times with an equal volume of NP40 lysis buffer to remove residual ethanol. Beads were centrifuged at 5000 RPM (tabletop centrifuge),
the supernatant was removed and the residual pellet was re-suspended in an equal volume of NP-40
lysis buffer. Following the third wash, 2 mg of brain lysate was incubated with 25 μL of GammaBind
Sepharose beads along with 1 μg of appropriate IgG control (Santa Cruz/Chemicon) in a total volume
of one mL in NP-40 lysis buffer and pre-cleared (to eliminate any non-specific binding) on a rotator at
4C for 30-45 minutes. Samples were then spun down at 14 000 RPM (tabletop centrifuge) for 5 min
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at 4C to remove anything that bound to the beads non-specifically. The supernatant was kept and
incubated with 25 μL GammaBind Sepharose beads along with the appropriate amount of desired
antibodies and incubated on a rotator overnight at 4 C. The following day, samples were centrifuged
at 14 000 RPM at 4 C for 10 minutes to pellet out the co-immunoprecipitated complexes. The
supernatant was removed and discarded and the pellet was re-suspended in 1 mL of NP-40 lysis buffer
for washing. This washing was repeated for a total of 5 times. Once washing was finished, samples
were prepared in 1x SDS loading buffer and heated at 65C for 10 min. Samples were loaded onto a
10% polyacrylamide SDS gel and separated by SDS-PAGE for 45 minutes at 200V. The blots were
analyzed for the co-immunoprecipitation of FRS3.
2.12 Western Blot Analysis
Protein samples were prepared in 1X SDS loading buffer and boiled for 10 minutes at 65C.
Samples were then loaded onto a 10% SDS-polyacrylamide gel and separated by size via gel
electrophoresis (PAGE) at 200V for 45 minutes. Following separation, proteins were transferred
electrophoretically at 0.5A for 2 hours onto a 0.2 μm Immuno-blot PVDF membrane (BioRad). The
membrane was incubated for one hour in western blotting blocking buffer at room temperature.
Membranes were then incubated overnight on a shaker at 4C in the same blocking buffer with the
desired antibody of choice. Following primary antibody incubation, membranes were washed 5 times
for 5 minutes each on a shaker at room temperature in 1xTBST. Membranes were then incubated once
more in blocking buffer with horseradish peroxidase-conjugated secondary antibodies (anti-mouse
IgG, anti-rabbit IgG or anti-goat IgG all 1:5000; Cedarlane, ON, CA) for 2 hours on a shaker at room
temperature. Secondary antibody was removed through a series of 5 washes for 5 minutes each on a
shaker at room temperature in 1x TBST. Membranes were then incubated in Western Lightening PlusECL Oxidizing Reagent Plus (PerkinElmer, MA, USA) and visualized using the BioRad ChemiDocX.
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2.13 Defining ‘Co-localized’
The Zeiss LSM Imaging software was used to define co-localization within this thesis. The
software defines co-localization by plotting the pixels of any said image onto a graph. Using the top
2% of pixels as a threshold, the software identifies overlapping pixels that are above the threshold
intensity level. These overlapping pixels are displayed on the co-localized panel as yellow dots.
2.14 Post synaptic density preparation
Cortices from Adult (~p60) mice were homogenized in 10 mL of a 0.32M sucrose solution (4
mM HEPES, pH 7.4 , PMSF, Sodium Vanadate, aprotenin, leupeptin) with the use of Teflon on glass
until mixture is homogenous. Minced cortices were then spun in the ultracentrifuge (SW4ITI rotor) for
10 minutes at 14,000 xg. The resulting pellet was discarded and supernatant saved in a fresh centrifuge
tube. Supernatant was spun twice more for 10 minutes each spin at 710 xg using the same rotor.
Supernatant was then spun at 9000 xg (still utilizing the same rotor) for 15 minutes. The pellet was
resuspended in 10 mL of 0.32M sucrose solution (as described above) and spun at 10 000 xg for 15
minutes. The subsequent pellet was saved. Cells were lysed using 9 volumes of distilled water and
1mM HEPES pH 7.4 (resulting in a hypotonic solution) and rotated at 4C for 30 minutes. If
necessary, the solution was brought up to 10 mL with dH2O, and spun at 25 000 xg for 20 minutes.
Pellet was saved and re-suspended in 2.5 mL of 0.25M sucrose solution (1 mM HEPES, pH7.4). A
sucrose gradient was set up as follows: 2.5 mL of each sucrose solution (0.25, 0.8, 1.0 and 1.2 M) was
carefully pipetted in order of decreasing molarity, one on top of each other. The final/top phase
(0.25M) contains the homogenate. The gradient was spun at 65 000 x g for two hours at 4C. Tape was
carefully placed on desired phase to prevent tube cracking upon phase removal. With an 18 gauge
needle, the synaptosomal plasma membrane (phase between 1.0M and 1.2M sucrose gradients) was
removed. A protein determination assay was run on the sample (two cortices should yield
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approximately 4mg/mL). Sample was then solubilized with an equal volume of Triton X-100 and spun
at 25 000 xg in the ultracentrifuge (TLA 120.2 rotor). Pellet was re-suspended in 100L loading buffer
(10% glycerol, 1% SDS) and heated at 65C for 10 minutes. Samples were then ready to be resolved
on a gel for subsequent analysis.

Chapter 3-Results
Given that FRS3, and not FRS2, was shown to be a microtubule binding protein, it is
hypothesized that FRS3 interacts with acetylated  tubulin (or other known proteins that bind
microtubules such as MAP2 or tubulin) to regulate microtubule stability and/or that it regulates the
transport of cargo and/or organelles. In order to address this, several co-immunoprecipitations studies
were performed with various microtubule-associated proteins thought to contribute to stability and/or
involved in molecular transport. Secondly, a post-synaptic density preparation was done in order to
determine if FRS3 may also be involved in short-range transport and/or is being actively transported
along actin filaments. Thirdly, FRS3 was knocked down in SN56 cells, prior to inducing them to
differentiate into cholinergic-like neurons, in order to determine if the presence of FRS3 has a
protective/stabilizing effect on microtubules and the cell‟s ability to extent neurites when subjected to
nocodazole (a microtubule depolymerizing agent). To control for loading, equal amounts of both
control and knockdown samples were analyzed by western blot

for -actin. Fourth,

immunocytochemistry was performed with antibodies directed against proteins shown to interact with
FRS3 by co-ip approaches in order to analyze their subcellular distribution as well as the extent of colocalization.
Lastly, since the expression of FRS3 initiates with the birth of cortical neurons, and is coincident
with their migration during cortical development, it is hypothesized that FRS3 has a fundamental role
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in cortex development by providing microtubule stability and ensuring proper cortical neuron
migration. To begin to address this, I assayed the effect of FRS3 knock-down first in E18 hippocampal
neurons in order to determine the effect of loss of FRS3 on cell phenotype. It is important to note that
hippocampal rather than cortical neurons were used due to the nature of which they grow in culture.
Cortical neurons grow in close proximity to each other making it difficult to distinguish one neuron
and its neurites from another; hippocampal neurons grow far apart from one another and thus were
more appropriate for statistical analysis. In order to eliminate the possibility of any outcome being a
result of altered FGF signaling, FRS2 knockdowns were also completed as a control. To complement
this data, FRS3 was also knocked down via adenovirus expression of the Cre recombinase following
virus infection in cortical neurons isolated from FRS3 floxed mice. In order to further support the
differences in phenotype being a direct result of the role of FRS3 in providing microtubule stability
rather than reflecting the loss of FGF signaling and/or an indirect effect of cell death (lipofectamine
can itself be toxic to neurons), knockdown plates were stained with cleaved-caspase 3, a marker of
apoptosis. To provide a positive control, separate plates were treated with campothecin, a cytotoxic
alkaloid that causes apoptosis and they were similarly stained for cleaved-caspase 3.

3.1 FRS3 interacts with acetylated  and  III tubulin in vitro via co-immunoprecipitation assays
and co-localizes with both proteins in cultured E18 hippocampal neurons.
FRS3 has previously been shown to be a microtubule-binding protein (Hryciw et al., 2010). As I
have hypothesized that FRS3 interacts with microtubules to regulate stability and molecular transport,
it was thus logical to assess the type and consistency of the interaction between FRS3 and a) acetylated
 tubulin, a post-translationally modified and stable form of microtubule and b)  III tubulin, a marker
of post-mitotic neurons (Hryciw et al., 2010). To this end, the potential interaction of FRS3 with
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acetylated  tubulin and  III tubulin was assessed through co-immunoprecipitation assays. In order to
complement these assays, immunohistochemistry of endogenous protein expression was also
employed to assess the co-localization of FRS3 with both proteins in primary hippocampal neurons.
As shown in Figure 3.1A, FRS3 consistently co-immunoprecipitated with acetylated  tubulin at
varying ages beginning at E18 up until adulthood (n = 15). In agreement with this, FRS3 was shown to
have strong co-localization with acetylated  tubulin throughout the entire neuron (Figure 3.1 C). In
addition, FRS3 consistently co-immunoprecipitated with  III tubulin, with more interaction occurring
at later ages (Figure 3.1A). Strong co-localization throughout the entire neuron was also displayed
between FRS3 and  III tubulin (Figure 3.1 D). Importantly, both antibodies were shown to correctly
immunoprecipitate their respective proteins (Figure 3.1 B).

Figure 3.1 (A) FRS3 consistently co-immunoprecipitates with both acetylated  tubulin and III
tubulin. Two mgs of protein from brain lysate in the indicated ages above were immunoprecipitated
with 1.0 g of the displayed antibodies. Fifty g of whole cell lysate (WCL) was loaded as a positive
control and mouse IgG was loaded as a negative control. Samples were resolved on a 10%
polyacrylamide gel and analyzed via western blot for FRS3 at a dilution of 1:4000. Conditions were
identical for all blots above. N = 15
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B

Figure 3.1 (B) Immunoprecipitations of acetylated  tubulin and  III tubulin. One mg of P1
whole brain lysate was immunoprecipitated with 1.0 g of displayed antibody. Fifty g of protein in
the form of whole brain lysate was loaded as a positive control and mouse IgG was loaded as a
negative control. It was shown that both antibodies were able to immunoprecipitate their respective
proteins efficiently.
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C

Figure 3.1 (C) FRS3 co-localizes with acetylated  tubulin in E18 hippocampal neurons. E18
hippocampal neurons were fixed and stained at 7DIV with FRS3 (green) acetylated  tubulin (red).
Images were taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. Scale bars
represent 20 m. Acetylated  tubulin appears to have strong co-localization with FRS3 throughout
the entire neuron. Co-localization is represented by the top 2% pixel overlap.
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D

Figure 3.1 (D) FRS3 co-localizes with III tubulin in E18 hippocampal neurons. E18 hippocampal
neurons were fixed and stained at 7DIV with FRS3 (green)  III tubulin (red). Images were taken with
a 63X objective lens on a Zeiss LSM510 confocal microscope.  III tubulin appears to have strong colocalization with FRS3 throughout the entire neuron. Scale bars represent 20 m. Co-localization is
represented by the top 2% pixel overlap.
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3.2 FRS3, but not FRS2, is present in the post-synaptic density
Since FRS3 has been shown to interact with molecular motors involved in long-range transport
along the axon (Li, unpublished) , I then wanted to determine whether FRS3 was also found at the
extremities of a neuron and potentially involved in short-range transport as well. Thus, a post-synaptic
density preparation from P60 mouse brain was prepared, run on a gel and blotted for the presence of
either FRS2 or FRS3. As shown in Figure 3.2 (A,B), I found that FRS3, but not FRS2, is, in fact,
present in the post-synaptic density fraction. This not only suggests that FRS3 may be involved in
short-range transport along actin filaments, but it further supports a separate role for FRS3 in cortical
neurogenesis other than a single role in FGF signaling. These data further support the model that
FRS3 and FRS2 serve different roles in neurons.
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A

Figure 3.2 (A) Post-synaptic density preparation probed for the presence of FRS3. PSD samples
were prepared from P60 mouse cortices and probed for the presence of FRS3 (1: 10 000). PSD 95 and
tubulin were used as experimental positive and negative controls, respectively (1: 2000;1: 10 000). As
a positive loading control, 50 ug of E18 whole cell lysate was used in each blot. N=3
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B

Figure 3.2 (B) Post-synaptic Density preparation probed for the presence of FRS2. PSD samples
were prepared from P60 mouse cortices and probed for the presence of FRS2 (1: 2000). ). PSD 95 and
tubulin were used as experimental positive and negative controls, respectively (1: 2000;1: 10 000). As
a positive loading control, 50 ug of P0 whole cell lysate was used in each blot. N=3
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3.3 FRS3 interacts with motor proteins KLC and KHC in vitro via co-immunoprecipitation
assays and co-localizes with both proteins in cultured E18 hippocampal neurons.
I hypothesized that FRS3 interacts with  III tubulin, in part, to modulate post-mitotic neuron
function (particularly the transport of cargo and organelles) for the following reasons: a) FRS3
interacts with  III tubulin which is a marker of post-mitotic neurons (Hryciw et al., 2010), b) FRS3
has been shown to co-localize with  III tubulin in the cortical plate in neuroepithelia (Hryciw et al.,
2010) and c) FRS3 is found in the PSD, which suggests it is being actively transported. Based on these
findings, it was then of value to investigate whether FRS3 interacts with a particular molecular motor
protein. This was done via co-immunoprecipitation assays with both KHC and KLC both of which are
part of the kinesin family of motors involved in anterograde transport (Cai and Sheng, 2009). It should
be noted that FRS3 did not interact with the dynein family of molecular motors, indicating specificity
in FRS3‟s binding partners. In order to complement these assays, immunocytochemistry was also
employed to assess FRS3‟s co-localization with both proteins in primary neurons. As shown in Figure
3.3 A, FRS3 was found to co-immunoprecipitate consistently with both KHC and KLC, (with negative
interaction with Dynein). However, with the use of ICC, different results were observed between the
co-localization of FRS3 and KLC or KHC. Namely, FRS3 was found to show strong co-localization
with KHC in both neurites and the cell body (Figure 3.3 C & D), whereas KLC showed punctate
staining that sits on top of the neurites with extremely weak co-localization with FRS3 (Figure 3.3 E ).
Both antibodies were shown to immunoprecipicate their respective proteins efficiently (Figure 3.3 B).
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A

Figure 3.3 (A) FRS3 consistently co-immunoprecipitates with kinesin motor proteins KHC and
KLC, but not Dynein. Two mg of protein from brain lysate was immunoprecipitated with 1.0 g of the
displayed antibodies. Fifty g of whole cell lysate (WCL) was loaded as a positive control and mouse
and goat IgG were loaded as negative controls. Samples were resolved on a 10% polyacrylamide gel and
analyzed by western blot for FRS3 at a dilution of 1:4000. N=9 (KHC) N=3 (KLC) N=11 (Dynein)

B

Figure 3.3 (B) Immunoprecipitations of Kinesin Heavy Chain, Kinesin Light Chain and Dynein.
One mg of P7 whole brain lysate was incubated with indicated amoung of displayed antibody. Fifty g
of protein in the form of whole brain lysate was loaded as a positive control and mouse IgG was
loaded as a negative control. It was shown that both antibodies were able to immunoprecipitate their
respective proteins efficiently. (KLC & Dynein blot completed by Alfonso Dietrich).
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C

Figure 3.3 (C) FRS3 co-localizes with KHC in E18 hippocampal neurons. E18 hippocampal
neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) KHC (red;1:250). Images were
taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. KHC appears to have strong
co-localization with FRS3 around the cell body and throughout the axon hillock with some staining
located in the nucleus. Scale bars represent 20 m. Co-localization is represented by the top 2% pixel
overlap.
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D

Figure 3.3 (D) FRS3 co-localizes with KHC in E18 hippocampal neurons. E18 hippocampal
neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) KHC (red; 1:250). Images were
taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. KHC appears to have strong
co-localization with FRS3 along the neurites. Scale bars represent 10 m. Co-localization is
represented by the top 2% pixel overlap.
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E

Figure 3.3 (E) FRS3 co-localizes weakly with KLC in E18 hippocampal neurons. E18
hippocampal neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) KLC (red; 1:250).
Images were taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. KLC appears
to have very weak co-localization with FRS3 along the neurites and cell body. Scale bars represent 20
m. Co-localization is represented by the top 2% pixel overlap.
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immunoprecipitations assays and co-localizes with Shank 2 in cultured E18 hippocampal
neurons.
Since FRS3 was found in the PSD, it was of interest to determine whether FRS3 had any
interactions with some of the proteins located in the PSD. To further support this finding, a coimmunoprecipitation assay was utilized in order to determine whether FRS3 interacted with either
Shank 2 or 3, both of which are found in the PSD and contain multiple domains that serve as molecular
scaffolds (Sheng and Kim, 2000). In order to complement these assays, immunohistochemistry was
employed to assess FRS3‟s co-localization with Shank 2. As shown in Figure 3.4A, FRS3 was found
to consistently co-immunoprecipitate with Shank 2 and Shank 3. Shank 2 expression in E18
hippocampal neurons appears to be concentrated around the axon hillock, the cell body and in the
nucleus; however it is more faintly distributed among the neurites. It strongly co-localizes with FRS3
in the neurites and around the axon hillock but has very little to no co-localization around the cell body
and in the nucleus where there is a lack of FRS3 expression (Figures 3.4 B & C)
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Figure 3.4 (A) FRS3 consistently co-immunoprecipitates with PSD scaffolding proteins
Shank 2 & 3. Two mg of protein from P0 brain lysate was incubated with 1.0 g of the
displayed antibodies. Fifty g of whole cell lysate (WCL) was loaded as a positive control and
mouse IgG were loaded as negative controls. Samples were resolved on a 10% polyacrylamide
gel and analyzed by western blot for FRS3 at a 1:4000 dilution. N=5 (Shank 2) N=3 (Shank 3)

B

Figure 3.4 (B) FRS3 co-localizes with Shank 2 in E18 hippocampal neurons. E18
hippocampal neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) Shank 2 (red;
1:200). Images were taken with a 63X objective lens on a Zeiss LSM510 confocal microscope.
Shank 2 appears to have strong co-localization with FRS3 around the cell body with heavy
staining found in and around the nucleus. Scale bars represent 10 m. Co-localization is
represented by the top 2% pixel overlap.
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C

Figure 3.4 (C) FRS3 co-localizes with Shank 2 in E18 hippocampal neurons. E18 hippocampal
neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) Shank 2 (red; 1:200) Images were
taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. Shank 2 is not as abundant
in the neurites as show but still maintains fairly strong co-localization with FRS3. Scale bars represent
10 m. Co-localization is represented by the top 2% pixel overlap.
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3.5 FRS3 interacts with microtubule-associated proteins MAP2, Doublecortin and Tau in vitro
via co-immunoprecipitations assays and co-localizes with MAP2 in E18 hippocampal cell
cultures.
Since FRS3 was found to bind microtubules and is proposed to be involved in microtubule
stability, it was assessed whether FRS3 interacted with microtubule-associated proteins that confer
stability. To this end, co-immunoprecipitations were done with FRS3 and the following microtubuleassociated proteins: MAP2 (involved in microtubule assembly and stabilization) (Dehmelt and
Halpain, 2005), Doublecortin (stabilizes microtubules and causes bundling) (Horesh et al., 1999) and
Tau (modulates the stability of axonal microtubules) (Dehmelt and Halpain, 2005). FRS3 was shown
to interact very consistently with Doublecortin, MAP2 and Tau (Figure 3.5 A). In order to complement
these assays, immunocytochemistry was employed to assess FRS3‟s co-localization with MAP2.
MAP2 displays punctate staining along the neurites with very little co-localization with FRS3 (Figure
3.5 C and D). All three proteins were shown to successfully immunoprecipitate their respective
proteins (Figure 3.5 B)
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A

Figure 3.5 (A) FRS3 consistently co-immunoprecipitates with MT stabilizing proteins
Doublecortin, MAP2 and Tau. Two mg of protein from brain lysate in the indicated ages above were
immunoprecipitated with 1.0 g of the displayed antibodies. Fifty g of whole cell lysate (WCL) was
loaded as a positive control and mouse or goat IgG were loaded as negative controls. Samples were
resolved on a 10% polyacrylamide gel and analyzed by western blot for FRS3 at a 1:4000 dilution.
N=5 (Doublecortin & MAP2) N=7 (Tau)

B

Figure 3.5 (B) Immunoprecipitations of MAP2, Tau and Doublecortin. One mg of whole brain
lysate was incubated with indicated amount of displayed antibody. Fifty g of protein in the form of
whole brain lysate was loaded as a positive control and goat/mouse IgG was loaded as a negative
control. It was shown that all three antibodies were able to immunoprecipitate their respective proteins
efficiently.
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C

Figure 3.5 (C) FRS3 co-localizes weakly with MAP2 in E18 hippocampal neurons. E18
hippocampal neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) MAP2 (red; 1:200).
Images were taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. MAP2 displays
punctate staining appearing to sit on top of the neurites weakly co-localizing with FRS3. Scale bars
represent 50 m. Co-localization is represented by the top 2% pixel overlap.
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D

Figure 3.5 (D) FRS3 co-localizes weakly with MAP2 in E18 hippocampal neurons. E18
hippocampal neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) MAP2 (red; 1:200).
Images were taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. MAP2 is also
found within the neurite co-localizing in punctate manner with FRS3. Scale bars represent 10 m. Colocalization is represented by the top 2% pixel overlap.
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3.6 FRS3 interacts with Fibroblast Growth Factor Receptor FLG in vitro through coimmunoprecipitations assays and co-localizes with FLG in E18 hippocampal cell cultures.
Aside from the interaction between FRS3, an adapter protein with its upstream receptors, Flg is
considered cargo as it is actively transported via molecular motors (Arimura et al., 2009); therefore it
was of interest to investigate whether FRS3 had any interaction with this cargo, which would further
support a role for FRS3 in transport. To address this, a co-immunoprecipitation was done with FRS3
and

Flg

(FGFR

1).

FRS3

was

shown

to

consistently

immunoprecipitate

with

Flg.

Immunocytochemistry was also done between both proteins in order to further complement the above
assays and gain more knowledge regarding the nature of their interaction. Flg displays a punctate
pattern of staining which is concentrated around the cell body and axon hillock with fairly strong colocalization with FRS3 (Figure 3.6 C & D).
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Figure 3.6 (A) FRS3 consistently co-immunoprecipitates with Fibroblast Growth Factor
Receptor2/Flg. Two mg of protein from P1 brain lysate were incubated with 1.0 g of the displayed
antibodies. Fifty g of whole cell lysate (WCL) was loaded as a positive control and goat IgG was
loaded as a negative control. Samples were resolved on a 10% polyacrylamide gel and analyzed by
western blot for FRS3 at a 1:4000 dilution. N=3

B

Figure 3.6 (B) Immunoprecipitations of Flg. One mg of whole brain lysate was incubated with
indicated amount of displayed antibody. Fifty g of protein in the form of whole brain lysate was
loaded as a positive control and goat IgG was loaded as a negative control. It was shown that the
antibody was able to immunoprecipitate its respective protein efficiently.
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C

Figure 3.6 (C) FRS3 co-localizes weakly with Flg in E18 hippocampal neurons. E18 hippocampal
neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) Flg (red; 1:200). Images were
taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. Flg appears to stain in a
punctate pattern and is abundant around the cell body and weakly co-localizes with FRS3. Scale bars
represent 10 m. Co-localization is represented by the top 2% pixel overlap.
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D

Figure 3.6 (D) FRS3 co-localizes weakly with Flg in E18 hippocampal neurons. E18 hippocampal
neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) Flg (red; 1:200). Images were
taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. Flg shows fairly strong colocalization with FRS3 around the cell body and in the axon hillock and is more dispersed, colocalizing in a weaker fashion with FRS3 along the neurites. Scale bars represent 20 m. Colocalization is represented by the top 2% pixel overlap.
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3.7 FRS3 interacts with synaptic vesicle-related proteins Bassoon, Syntaxin I and Synaptophysin
in vitro via co-immunoprecipitations assays and co-localizes with Synaptophysin in E18
hippocampal cell cultures.
Since FRS3 is hypothesized to modulate molecular transport and has been found to interact with
the molecular motor kinesin, it was of interest to further investigate whether FRS3 interacts with cargo
being transported along a neuron. Synaptic vesicles are the mode by which cargo is transported along
neuronal processes and thus it was logical to address the potential interactions of FRS3 with proteins
related to the synaptic vesicle. FRS3 was found to have very consistent co-immunoprecipitation with
Bassoon (Figure 3.6 A), a protein involved in bringing the synaptic vesicle in close proximity to the
presynaptic terminal (Shapira et al., 2003). FRS3 was also shown to have consistent coimmunoprecipitation with the t-SNARE complex protein Syntaxin I which interacts with the vSNARE complex proteins synaptophysin and synaptobrevin (Figure 3.7 A&B). The SNARE complex
mediates the binding and fusion of synaptic vesicles with the pre-synaptic membrane as well as
neurotransmitter release (Sudhof, 2000, Figure 3.7C). It is important to note that there was no
interaction found with SNAP 25, another component of the SNARE complex, thus indicating
specificity. In order to complement these assays, ICC was utilized in order to visualize FRS3‟s colocalization with Synaptophysin. Synaptophysin is more concentrated around the cell body where it
co-localizes with FRS3 and is more punctate and sparse along the neurites, sometimes sitting on top of
the neurites, in E18 hippocampal neurons (Figure 3.7 D and E)
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A

Figure 3.7 (A) FRS3 consistently co-immunoprecipitates with Bassoon, Syntaxin I and
Synaptophysin but not SNAP 25. Two mg of protein fro brain lysate, at the ages indicated above, were
incubated with 1.0 g of the displayed antibodies. Fifty g of whole cell lysate (WCL) was loaded as a
positive control and goat IgG were loaded as negative controls. Samples were resolved on a 10%
polyacrylamide gel and analyzed by western blot for FRS3 at a 1:4000 dilution. N=3 (Bassoon &
Synaptophysin) N=5 (Syntaxin I)

B

Figure 3.7 (B) Immunoprecipitations of Syntaxin I, Synaptophysin and SNAP 25. One mg of
whole brain lysate was incubated with indicated amoung of displayed antibody. Fifty g of protein in
the form of whole brain lysate was loaded as a positive control and mouse IgG was loaded as a
negative control. It was shown that all antibodies were able to immunoprecipitate their respective
proteins efficiently.
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C
C

Figure 3.7 C. Schematic of the SNARE complex proteins. The SNARE complex of proteins is
composed of Synaptobrevin, Syntaxin-1 and SNAP25. Synaptophysin binds synaptobrevin, which is
used to anchore the synaptic vesicle to the SNARE complex. SNAP 25 binds the plasma membrane,
anchoring the entire complex. Lastly, Syntaxin-1 is used to pull the synaptic vesicle through the
plasma membrane for exocytosis (Sudhof and Rizo, 2011).
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D

Figure 3.7 (D) FRS3 co-localizes weakly with Synaptophysin in E18 hippocampal neurons. E18
hippocampal neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) Synaptophysin (red;
1:500). Images were taken with a 63X objective lens on a Zeiss LSM510 confocal microscope.
Synaptophysin staining is concentrated around the cell body and axon hillock and punctate along the
neurites with some FRS3 co-localization. Scale bars represent 50 m. Co-localization is represented by
the top 2% pixel overlap.
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E

Figure 3.7 (E) FRS3 co-localizes weakly with Synaptophysin in E18 hippocampal neurons. E18
hippocampal neurons were fixed and stained at 7DIV with FRS3 (green; 1:2000) Synaptophysin
(red1:500). Images were taken with a 63X objective lens on a Zeiss LSM510 confocal microscope.
Synaptophysin has more disperse, punctate staining appearing to sit on top of the neurites with little
co-localization with FRS3.
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3.8 Loss of FRS3 results in increased sensitivity to the microtubule depolymerizing agent
nocodazole.
As FRS3 has been hypothesized to provide microtubule stability, I then tested whether loss of
FRS3 would have any effect on the sensitivity of microtubules to nocodazole, a depolymerizing agent.
SN56 cells were transfected with either control or FRS3 shRNAs upon reaching 75% confluency. Four
shRNAs were tested for their ability to knockdown FRS3 in SN56 cells, and shRNA #2 was chosen for
this experiment (Figure 3.8A). Cells were then differentiated with serum free media and cAMP 24
hours later. Varying concentrations of nocodazole were then added to each set of cells for a total of
two hours. A tubulin extraction buffer was then applied to the cells and each sample was subject to
high-speed centrifugation to separate the free tubulin from the polymerized tubulin. Both fractions
were separately analyzed by western blot for tubulin. As expected, with increasing concentration of
nocodazole there is subsequently more free tubulin and less polymerized tubulin found in all samples
(Figure 3.8 B). When FRS3 was depleted, there was significantly more free tubulin and less
polymerized tubulin in comparison to control plates (Figure 3.8 B). This observation suggests that
FRS3 does provide a stabilizing/protective effect on microtubules. In order to eliminate the possibility
of these observations being a result of unequal amounts of protein loaded in each sample, equal
amounts of each sample from each fraction were resolved on a 10% polyacrylamide gel and blotted for
-actin as a loading control (Figure 3.8 C). Note: The efficiency of FRS3 knockdown via shRNA was
assessed with the use of SN56 cells. Cells were transfected 24 hours after being plated with
Lipofectamine 2000 transfection reagent and differentiated 24 hours following transfection with
cAMP. Cells were lysed one day after differentiation, resolved on a 10% polyacrylamide gel and
analyzed by western blot for the presence of FRS3.
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A)

Figure 3.8 (A) FRS3 shRNAs efficiently knock down endogenous FRS3 expression in SN56 cells.
Cells were transfected with Lipofectamine 2000 transfection reagent 24 hours after plating and
differentiated with cAMP 24 hours after transfection. One day following transfection, cells were lysed
and resolved on a 10% polyacrylamide gel and analyzed by western blot for the presence of FRS3 (1:
4000). The blot was stripped and re-probed for -actin (1: 10 000) to serve as a loading control.
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B)

Figure 3.8 (B) Loss of FRS3 increases nocodazole sensitivity and decreases tubulin
polymerization in vitro. SN56 cells were transfected with either a control or FRS3 shRNA 2 for 48
hours, followed by differentiation with cAMP for 24 hours. Cells were then treated with varying
concentrations of nocodazole for 2 hours, lysed and then assayed for reconstitution of polymerized
tubulin at 37C. Samples were resolved on a 10% polyacrylamide gel and analyzed by western blot for
tubulin (1:10 000). N=4
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C)

Figure 3.8 (C) Loss of FRS3 increases nocodazole sensitivity and decreases tubulin
polymerization in vitro. Equal amounts of control and FRS3 shRNA from the free tubulin and
polymerized tubulin fractions were prepared and resolved on a 10% polyacrylamide gel. The blots
were probed for the amount of beta-actin (1:10 000) present to serve as a loading control.
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3.9 Loss of FRS3, but not FRS2, expression in E18 hippocampal neurons results in reduction in
both length and number of neurites.
Since it has been hypothesized that the interaction of FRS3 with microtubules provides stability
to indirectly ensure proper cortical neuron migration and maturation (neurite extension), it was of great
interest to determine what effects the loss of FRS3 would have on neuron morphology. With the use of
Lipofectamine 2000 transfection reagent, E18 hippocampal neurons were transfected with either a Cy3 tagged control siRNA or FRS3 siRNA 24 hours after plating. Cells were fixed and stained with
FRS3 and  III tubulin two days after transfection. Cells were visualized under a confocal microscope
at 63X magnification and observed for any difference in phenotype in comparison to control. Upon
comparing the knockdown and control cells (Figure 3.9 A), it was apparent that loss of FRS3 affected
both the length and number of neurites; in fact most neurons lacked neurites completely (Figure 3.9 B).
To exclude a role for FRS3 in FGF signaling as the cause of observed neurite loss, FRS2 was also
knocked down in the exact same manner. Interestingly, loss of FRS2 resulted in no visible difference
in morphology in comparison to control plates (Figure G & H). In addition, the length and number of
neurites was measured for each set of knockdowns (Figure F & I), by taking a set of 10 random
pictures from each plate and utilizing the LSM Image Browser program to measure the length of
neurites relative to the magnification of each picture. Pictures of each set of knockdowns were also
taken at a lower magnification to disprove any bias. The difference in the length and the number of
neurites between FRS3 knockdown and control plates was statistically significant; whereas the
difference with the FRS2 knockdown plates was not (Figure F & I). As a whole, this suggests that it is
FRS3‟s role in providing microtubule stability and NOT its role in FGF signaling that accounts for the
lack of neurites when there is a loss of FRS3. Note: The efficiency of both siRNAs were tested against
endogenous FRS3 expression in differentiated SN56 cells. Cells were transfected with Lipofectamine

71

2000 transfection reagent 24 hours after plating and differentiated 24 hours after transfection with
cAMP. Cells were lysed one day following differentiation and resolved on a 10% polyacrylamide gel
and analyzed by western blot for the presence of FRS3. As shown in Figure 3.9 J, both siRNAs are
able to effectively knock down their targeted protein in culture.
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A) Control siRNA
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B) FRS3 siRNA

Figure 3.9 A & B. Loss of FRS3 expression reduces both number and length of neurites. E18
hippocampal neurons were transfected 24 hours after plating with either A) control scrambled siRNA
or B) FRS3 siRNA with lipofectamine 2000 transfection reagent. Cells were fixed 48 hours after
transfection and stained for FRS3 (green; 1: 2000) and Beta III tubulin (red; 1:2000). Images were
taken with a 63X objective lens on a Zeiss LSM510 confocal microscope. Scale bars represent 50 m.
As shown, neurite outgrowth is abrogated upon the loss of FRS3 in comparison to control.
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C) Control siRNA
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D) FRS3 siRNA
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E) FRS2 siRNA

Figure 3.9 C, D & E Lower magnification (40x) pictures depicting that loss of FRS3, but not
FRS2, expression reduces both number and length of neurites. In order to eliminate any bias,
zoomed out pictures of A) control and B) FRS3 siRNA C) FRS2 siRNA plates were taken in order to
view the effects upon the loss of FRS2/FRS3 expression on a greater scale. Images were taken with a
40x objective lens on a Zeiss LSM510 confocal microscope.
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F

Figure 3.9 (F) Loss of FRS3 results in a significant reduction in the number and length of
neurites. Transfected E18 hippocampal neurons were scored for number and total neurite length. Ten
fields were counted per condition. A student‟s T test was performed resulting in p values of 0.0022 and
0.0014, respectively.
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G) Control siRNA

79

H) FRS2 siRNA

Figure 3.9 G & H Loss of FRS2 expression has no effect on both number and length of neurites.
E18 hippocampal neurons were transfected 24 hours after plating with either A) control scrambled
siRNA or B) FRS2 siRNA with lipofectamine 2000 transfection reagent. Cells were fixed 48 hours
after transfection and stained for FRS2 (green) and Beta III tubulin (red). Images were taken with a
63X objective lens on a Zeiss LSM510 confocal microscope. Scale bars represent 50 m. As shown,
neurite outgrowth is unaffected upon the loss of FRS2 in comparison to control.
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I)

Figure 3. 9 I) Loss of FRS2 does not affect in the number and length of neurites. Transfected E18
hippocampal neurons were scored for number and total neurite length. Ten fields were counted per
condition. A student‟s T test was performed resulting in p values of 0.69 and 0.57, respectively.
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J)

Figure 3.9 (J). FRS2 and FRS3 siRNAs effectively knock down their respective targets in SN56 cells.
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3.10 Cell death can be eliminated as cause for loss in neurite outgrowth upon loss of FRS3
expression
Due to the fact that the loss of FRS3 expression is caused via transfection with a somewhat
toxic transfection reagent, it could be argued that the abrogated neurite extension could be a result of
cell death from toxicity. To address this, first, a control plate was treated with 5 m camptothecin.
Camptothecin is a cytotxic alkaloid that induces apoptosis and subsequently increases detectable levels
of cleaved caspase-3. Cells were treated 24 hours after plating and fixed 16 hours later to allow for
optimal levels of cleaved caspase-3 to accumulate (Keramaris et al., 2000). Cells were stained for
cleaved caspase-3. In addition, untreated plates that were infected with siRNA (with the use of
Lipofectamine transfection reagent) were also fixed and stained for cleaved caspase-3. As to be
expected, cells treated with camptothecin displayed strong cleaved caspase-3 staining uniformly
throughout the dishes with damaged cell somas, characteristic of apoptosis (Figure 3.10 A), whereas
untreated, FRS3 siRNA transfected dishes displayed no cleaved caspase-3 staining and cell somas are
intact (Figure 3.10 B). This suggests that there is no significant apoptosis occurring due to transfection,
thus further supporting the notion that it is the loss of FRS3 that is the direct cause of the loss of
neurite extension.
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A) Treated with Campothecin (Control)

84

B) Untreated (FRS3 siRNA)

Figure 3.10 (A) & (B) Apoptosis is not present in siRNA transfected neurons. E18 hippocampal
neurons were treated with either siRNA or 5 m campothecin 24 hours after plating. SiRNA
transfected plates were fixed and stained with cleaved-caspase 3 antibody 48 hours after treatment.
Campothecin treated neurons were fixed and stained 16 hours after treatment. Images were taken at
20X objective with a Nikon Eclipse (TE2000-U) microscope .
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3. 11 Loss of FRS3 in E18 cortical neurons results in abolished neurite extension
To complement the knockdown data above, E18 cortical cultures were also utilized. The
difference being that these cultures were prepared from FRS3 floxed mice and were infected with a
Cre-recombinase adenovirus, thus resulting in almost complete FRS3 knockdown. Cells were infected
24 hours after plating at an MOI of 250. Cells were then fixed with 4% paraformaldehyde and stained
with  III tubulin and observed under a Nikon Eclipse (TE2000-U) microscope at 10X magnification.
Loss of FRS3 abolishes neurite extension and results in significantly reduced  III tubulin staining in
comparison to control (Figure 3.11 A & B). Cell bodies do remain intact however, disproving the
potential of cell death being the cause of a lack of neurite extension. This further supports the
hypothesis that FRS3 has a significant role in microtubule stability and neurite extension. It is
important to note that his data is preliminary and must be repeated.
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A) Control

Figure 3.11 A) Cre-recombinase-mediated loss of FRS3 in floxed E18 cortical neurons results in
abrogated neurite outgrowth. Cultures were infected with either a control virus (A) or an crerecombinase virus (B) 24 hours following plating at an MOI of 250. Cells were fixed 48 hours after
infection with 4% paraformaldehyde and stained with  III tubulin (red; 1:2000) and observed under a
Nikon Eclipse (TE2000-U) microscope at 10X magnification. Neurite extensions appears to be intact.
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B) Ad-Cre Virus

Figure 3.11 A) Cre-recombinase-mediated loss of FRS3 in floxed E18 cortical neurons results in
abrogated neurite outgrowth. Cultures were infected with either a control virus (A) or a Crerecombinase expressing virus (B) 24 hours following plating at an MOI of 250. Cells were fixed 48
hours after infection with 4% paraformaldehyde and stained with  III tubulin (red; 1:2000) and
observed under a Nikon Eclipse (TE2000-U) microscope at 10X magnification. Green represents the
fluorescent tag (GFP) on the adenonirus. It appears loss of FRS3 results in abolished neurite extension
and subsequently significant reduction in  III tubulin staining; cell bodies remain intact but clumped
together.
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Chapter 4-Discussion
Despite FRS3 being a part of the FGF family of signaling proteins and its similarities to FRS2,
there have recently been a number of structural and functional studies supporting the model that FRS3
has a separate role other than its role in FGF signaling (Hryciw et al., 2010). The most notable
difference between the two adapter proteins is their sub-cellular distribution in brain fractionation
studies (Hryciw et al., 2010). Specifically, FRS2 is exclusively associated with lipid-rafts whereas
FRS3 is found primarily in the soluble fraction, is a microtubule-binding protein and only a minor
amount is present in membrane fractions (Hryciw et al., 2010). This, in addition to several other minor
differences (in particular FRS2 expression being ubiquitous whereas FRS3 is primarily restricted to the
nervous system), opened up the possibility that FRS3 could be involved in additional roles in the
nervous system. To this end it was discovered that FRS3 expression begins with the birth of cortical
neurons and coincides with their migration in the developing cortex (Hryciw et al., 2010). It was not
only found to co-localize with acetylated  tubulin (a marker of migrating neurons and microtubule
stability) but also with  III tubulin, a marker of post-mitotic neurons (Hryciw et al., 2010; Creppe et
al., 2009). Furthermore, FRS3 was found to interact with various molecular motors and the
microtubule associated protein MAP2 in vitro (Chunhui Li, unpublished). These findings led to the
hypothesis that FRS3 regulates the maturation of neurons as well as post-mitotic neuron function by
either regulating microtubule stability and/or the intracellular transport of cargo and organelles.
The first part of this thesis was devoted to investigating the interactions of FRS3 with various
proteins involved in molecular transport within cortical and hippocampal neurons. A number of coimmunoprecipitation assays were completed in order to further investigate FRS3‟s binding partners.
The two proteins found to co-immunoprecipitate most consistently with FRS3 were acetylated 
tubulin and  III tubulin (Figure 3.1 A). This was to be expected as FRS3 had previously been shown
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to co-localize with acetylated  tubulin in migrating neurons as well as with  III tubulin in the cortical
plate in the developing neuroepithelia, and also binds to polymerized microtubules in vitro. (Hryciw et
al., 2010). Both proteins were also found to have strong co-localization in E18 hippocampal neurons
(Figure 3.1 C & D).  III tubulin expression increases with age during development as it is found in
post-mitotic neurons (Creppe et al., 2009). This can explain why FRS3 was found to consistently coimmunoprecipitate with  III tubulin at later ages (after E18). Given that acetylated  tubulin is a
marker of migrating neurons and is involved in microtubule stability, this interaction supports the
hypothesis that FRS3 could be involved in microtubule stability as well as neuron
migration/maturation. Furthermore,  III tubulin is found in post-mitotic neurons (Creppe et al., 2009),
suggesting a role for FRS3 in differentiated neurons as well.
Since FRS3 was found to bind microtubules, it was of interest to investigate whether it interacted
with other microtubule-associated proteins involved in conferring stability. Molecular motors were of
interest as they use microtubules as their tracks and are involved in critical processes in post-mitotic
neurons (Cai and Sheng, 2009). In this respect, FRS3 was found to consistently co-immunoprecipitate
with KLC and KHC, both of which are part of the kinesin family of motors involved in anterograde
transport (Cai and Sheng, 2009). The interaction with molecular motors could provide an explanation
as to the role of FRS3 in differentiated neurons, relating to its interaction with  III tubulin, thus
suggesting that FRS3 could regulate post-mitotic neuron function via molecular transport. Although
FRS3 interacts with both the heavy and light chains of the kinesin family of motors, their colocalization differs in E18 hippocampal neurons. While FRS3 strongly co-localizes with KHC in the
neurites and around the cell body (Figure 3.2 C) it has little to no co-localization with KLC, which has
punctate staining sitting „on-top‟ of the neurons (Figure 3.2 F). This differential co-localization could
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be explained by the fact that FRS3 could be directly interacting with KHC, which indirectly links it to
KLC, as they are both parts of the same motor.
Since FRS3 was found in the PSD (discussed below) it was of interest to investigate whether it
interacted with any proteins found in the PSD. In this regard, FRS3 was found to consistently coimmunoprecipitate with both Shank 2 and 3, both of which are scaffolding proteins in the PSD
(Naisbitt et al., 1999). In order to complement this data, immunocytochemistry was done with
antibodies to FRS3 and Shank 2 in E18 hippocampal neurons. As shown in Figure 3.3 B & C,. Shank 2
demonstrated strong co-localization with FRS3 around the cell body and in the axon hillock with faint
expression distally in the neurites. These results bring about two possibilities: a) since Shank 2 and 3
are scaffolding proteins, FRS3 may be involved in providing stability within the PSD in addition to
microtubules; b) FRS3 could be involved in the transport of these proteins to the PSD. It should be
noted that the dendritic spines that house the PSD are not formed in cell culture until P21 (Ivanov et
al., 2007), which could explain the diffuse staining pattern of Shank2.
As the focus of this thesis was directed at the interaction of FRS3 with microtubules, it was of
interest to determine what other microtubule-associated proteins could also be found in complex with
FRS3. Using the approach of co-immunoprecipitations, FRS3 was found to consistently form a
complex with the microtubule-associated proteins: Doublecortin, MAP2 and Tau. All three proteins
are involved in microtubule assembly and in providing microtubule stability (Horesh et al., 1999;
Dehmelt and Halpain, 2005). These observations further support the model that FRS3 interacts with
microtubules in order to confer stability which could occur in one of two ways: either FRS3 directly
provides stability to microtubules itself or it acts as an adapter/mediator protein allowing for the
binding of other proteins (such as the ones mentioned above) which themselves confer the stability. To
complement these observations, immunocytochemistry was performed with antibodies to FRS3 and
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MAP2 in E18 hippocampal neurons. Essentially, I found that the MAP2 staining was punctate and
dispersed throughout the neurites and demonstrated faint co-localization with FRS3.
Aside from interaction between FRS3 and Flg (FGFR1) via FGF signaling, it was of interest to
investigate whether it interacted with the receptor during transport. As a receptor involved in FGF
signaling, Flg is found in the membrane fraction, as it is a membrane-associated protein (Meyers et al.,
1995); however, receptors are often transported as cargo for recycling or degradation along
microtubules in the neuron (Arimura et al., 2009) and thus found in the cytosolic fraction where FRS3
is also found (Hryciw et al., 2010). FRS3 was found to consistently co-immunoprecipitate with Flg in
the brain. In order to complement this data and gain more insight as to the nature of the interaction
between both proteins, immunocytochemistry was done in E18 hippocampal neurons with antibodies
against both FRS3 and Flg. Flg displayed relatively strong co-localization with FRS3 (Figure 3.5 C &
D) around the cell body and axon hillock, with more disperse staining along the neurites. This suggests
that FRS3 may be mediating the transport of the FGF receptors (by providing microtubule stability) in
addition to its interaction with the FGFRs during FGF signaling.
Since FRS3 was found in the PSD fraction isolated from P60 mouse brains and was also found to
interact with kinesin motors, both of which suggest it is involved in long-range transport, the next step
was to investigate whether FRS3 interacted with specific cargo constituents suggesting that it could be
involved in their transport. It should be noted that FRS3 did not interact with dynein, suggesting that
FRS3 is involved primarily in anterograde transport processes. To investigate these processes, I found
that FRS3 consistently co-immunoprecipitated with Bassoon, Syntaxin I and Synaptophysin. All three
of these proteins are involved in synaptic vesicle docking, binding with the presynaptic membrane and
cargo release (eg. neurotransmitters). SNAP25 is also part of this complex, however, FRS3 was found
to have no interaction with this protein, suggesting specificity. The active zone is located at the tips of
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the axon and makes up part of the presynaptic membrane. It is the site where synaptic vesicles dock,
fuse and release neurotransmitters into the synaptic cleft (Shapira et al, 2003). Many proteins are
found at the presynaptic terminal, including components of the t-SNARE complex, particularly
Syntaxin I. This complex is responsible for promoting the docking and fusing of the synaptic vesicles
to the pre-synaptic membrane (Shapira et al., 2003). Bassoon is a modular protein that is part of an 80
nm dense core granulated vesicle named Piccolo transport vesicle (PTV) (Zhai et al., 2001). Bassoon
acts as a scaffolding protein, anchoring the synaptic vesicle and bringing it in close proximity to the
presynaptic membrane, thus facilitating neurotransmitter release (Shapira et al., 2003). Synaptophysin
is a transmembrane glycoprotein that is a major component of synaptic vesicle membranes and is part
of the v-SNARE complex. It is believed to play a role in the anchoring of synaptic vesicles to the
cytoskeletal matrix of the presynaptic membrane as well as having a regulatory role in
neurotransmitter release (Navone et al., 1984, 1986; Jahn et al., 1985; P. De Camilli et al., 1988). The
interaction of FRS3 with these proteins suggests a role for FRS3 in molecular transport. It could be
facilitating cargo binding to the molecular motors or acting as an adapter protein within the active zone
itself.
In order to determine whether FRS3 might also serve a role in molecular transport in the
recipient neuron, a PSD preparation was generated from adult mouse brains and examined for
expression of both FRS adapters. Interestingly, I found that FRS3, but not FRS2, was found in
abundance in adult PSD preparations similar to the PSD-95 adapter (Figure 3.7 A & B). The selective
inclusion of FRS3, but not FRS2, in PSDs further supports a diverging role between these 2 adapters.
Furthermore, it suggests that FRS3 is being actively transported to the PSD and could be involved in
both long-range transport (along the axon) and short range transport (within the axon terminal and
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dendrites). In conjunction with the co-immunoprecipitation data, its presence in the PSD could also be
providing stability as it interacts with PSD scaffolding proteins Shank 2 & 3.
Another approach in determining a potential role for FRS3 in microtubule function was to
investigate whether loss of FRS3 would have any effect on microtubule stability and sensitivity to
lower doses of nocodazole, a microtubule depolymerizing agent. Interestingly, I found that at lower
concentrations of nocodazole, a shift in the amount of free tubulin is observed between the control
plate and FRS3 knockdown, with more free tubulin present when FRS3 is knocked down via shRNA
(Figure 3.8 A). With higher concentrations of nocodazole, the amount of free tubulin levels off;
however, a significant difference in the amount of polymerized tubulin is still observed. There is far
less (with high dosages there is none) polymerized tubulin with loss of FRS3 in comparison to control
(Figure 3.8 A). This strongly supports the hypothesis that FRS3 facilitates microtubule stability as the
loss of FRS3 resulted in increased sensitivity to nocodazole. In order to eliminate the possibility of this
phenomenon being a direct result of varying protein concentrations in each sample, an equal amount of
control and FRS3 shRNA lysate for each sample was combined for each fraction and blotted for 
actin as a loading control. This provided more strength to the proposed hypothesis as equal amounts of
 actin were found in each sample (Figure 3.8 B).
Given that FRS3 is hypothesized to be involved in cortical maturation, it was important to
characterize how the loss of FRS3 impacts primary neuronal growth in culture. This was done by
knocking FRS3 down in E18 hippocampal neurons with the use of an FRS3 siRNA. Upon the loss of
FRS3 expression, neurite outgrowth appeared to be abrogated when compared to control plates, which
displayed a normal phenotype (Figure 3.9 A, B & C). Plates were stained for  III tubulin in order to
visualize the neurites. In order to eliminate bias, lower magnification (40X) pictures were also taken.
This was done in order to demonstrate that overall, the majority of neurons had little to no neurites
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when FRS3 was knocked down in comparison to control plates, which displayed healthy phenotypes
with long and multiple neurite extension (Figures 3.9 D & E). The differences were also quantified
between knock down and control plates. This was done by measuring the number and length of
neurites in 10 random fields from each dish. The difference in both length and number of neurites
between knockdown plates and control plates was significant (Figure 3.7 G & H) (length of neurites p
value: 0.0014; number of neurites: 0.0022). These results strongly suggest a role for FRS3 in
microtubule stability and neuron maturation. In order for neurons to properly extend neurites they
require stable, tightly regulated microtubule dynamics. It could also be inferred that FRS3 may even
have a role in cortical neuron migration because neurons utilize microtubules for migration; however
this would need to be investigated further. FRS2 was also knocked down in the same manner in order
to add strength to the above-proposed hypothesis as it could be argued that the impaired ability to
extend neurites could be attributed to the fact that FGF signaling is itself being affected via the loss of
FRS3. Consequently, upon the loss of FRS2, there is no significant difference in the ability to extend
neurites in comparison to controls (Figure 3.7 I, J, K & L) (length of neurites p value: 0.65 number of
neurites p value: 0.7). Again, this further supports the notion that FRS3 has a separate role other than
its role in FGF signaling and may be involved in providing microtubule stability and facilitating
neurite extension and thus is an important player in neuron maturation. Since neurons were transfected
with lipofectamine, which can be toxic to cells, it was important to show that there wasn‟t a significant
amount of apoptosis in transfected dishes in order to eliminate cell death as a reason for impaired
neurite extension. To this end, plates were treated with camptothecin, which causes apoptosis and
increases the detectable levels of cleaved caspase-3 expression. This was to serve as a control. These,
along with other untreated transfected plates were stained with cleaved caspase-3 antibody in order to
compare relative levels of apoptosis. Plates treated with campothecin displayed uniform cleaved
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caspase-3 staining throughout the entire dish whereas untreated (but transfected) plates displayed little
to cleaved caspase-3 staining.
To further complement the in vivo knockdown research, FRS3 floxed E18 cortical cultures were
utilized. These cultures were infected with an Adenovirus expressing Cre-recombinase to ensure an
efficient loss of FRS3 expression (far more effective and specific as this is directly targeting the gene
rather than the RNA) than siRNA transfection. Similar results to the FRS3 knockdown in E18
hippocampal neurons were observed. Control plates displayed normal  III tubulin staining along the
long neurite extensions, whereas in cells treated with the virus, there was little to no  III tubulin
staining as neurite extension was abolished. This provides more strength to the argument that FRS3
regulates microtubule stability and subsequently neurite outgrowth.

Conclusion
With the recent structural and functional studies displaying inherent differences between FRS3
and FRS2, it can be strongly suggested that there is a separate role for FRS3 in the nervous system
other than a role in FGF signaling. Since the major difference between the two signaling adapter
proteins was their ability to interact with microtubules, this element was the focus of my thesis.
Microtubules are extremely important to any cellular process, as they are the building blocks of the
cellular cytoskeleton (Downing and Nogales, 1998). In terms of the nervous system, microtubules play
an important role in neurogenesis. The regulation of microtubule stability and dynamics allows for
neuronal polarization, which in turn allows for neuron migration, differentiation, maturation and
consequently proper brain development (Conde and Caceres, 2009). Furthermore, they act as tracts
upon which molecular motors transport important cargo, which is also essential to neurogenesis
(Kaverina and Straube, 2011). The research completed in this thesis suggests two things: a) a potential
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role for FRS3 in the migrating, differentiating neuron (by regulating microtubule stability) and b) a
role for FRS3 in the post-mitotic/differentiated neuron. Supporting a role for FRS3 in the
differentiating neuron was led by its consistent interaction with acetylated  tubulin. FRS3 not only
consistently co-immunoprecipitated with acetylated  tubulin, but it was also found to strongly colocalize with it in migrating neurons in developing neuroepithelia (Hryciw et al., 2010). Since
acetylated  tubulin is associated with microtubule stability and FRS3 binds microtubules, this led to
the hypothesis that role of FRS3 in migrating neurons is to contribute to or facilitate microtubule
stability. Further supporting this notion was a) the interaction of FRS3 with microtubule associated
proteins Doublecortin, MAP2 and Tau, all of which confer microtubule stability; and b) Loss of FRS3
resulted in increased sensitivity to the microtubule de-polymerizing agent nocodazole. FRS3 was also
found to consistently interact with  III tubulin, a marker of post-mitotic neurons. The hypothesis that
FRS3 is also involved in post-mitotic neuron function was further supported by the knockdown results.
When neurons have migrated to the proper laminar location in the cortex, they begin to differentiate
(by leaving the cell cycle) and eventually mature by extending out neuronal processes (Creppe et al.,
1999). Upon the loss of FRS3 expression, neurons lost the ability to extend out neurites thus strongly
supporting the hypothesis that FRS3 is also involved in post-mitotic neuron function by regulating
maturation. This regulation could be via microtubule dynamics as the regulation of microtubule
extension and retraction allows for neurite growth. Furthermore, once neurons have matured, they
require the binding of microtubule-associated proteins, which confer microtubule stability. This
process may be facilitated through FRS3 or FRS3 could be another source of stabilization. This is
consistent with the fact that FRS3 interacts with microtubule-associated proteins such as Doublecortin,
MAP2 and Tau. Finally, FRS3 was shown to interact with various components of molecular transport.
Molecular transport is equally important in both the immature migrating neuron as well as the mature
97

differentiated neuron. FRS3 was found to interact with molecular motors (KHC/KLC) as well as
synaptic vesicle-associated proteins Bassoon, Syntaxin I and Synaptophysin. This, in conjunction with
the presence of FRS3 in the PSD, suggests that FRS3 is being actively transported and is involved in
regulating molecular transport. Since FRS3 does not display punctate staining, as would an adapter
protein, and rather shows uniform staining throughout the neurite, this suggests that it is facilitating the
binding of molecular motors to the microtubule filaments. In addition, FRS3‟s interaction with
synaptic vesicle components (Bassoon, Syntaxin I and Synaptophysin) and PSD scaffolding proteins
(Shank 2 & 3) suggests that it may also be involved in facilitating neurotransmitter release or simply
providing stability in PSD.
Although FRS3 has always been associated with FGF signaling, it is becoming increasingly
apparent that it serves other important roles in the developing brain.

Future Directions
A limitation of this thesis was not having the FRS3 floxed mouse line bred with other Crerecombinase mouse lines. As such, knockdown studies were restricted to cell culture only, and
Cre-recombinase was administered through viral infection. There are two types of Crerecombinase mouse lines that would be valuable in further elucidating the role of FRS3 in cortex
development. First, a Foxg1 Cre-recombinase line (Hebert & McConnell, 2000) would be
employed as Foxg1 expression is restricted to the brain & testes and is detectable as early as the
three-somite stage (~E8) in the anterior neural ridge, which underlies the neural plate. By E10 it is
expressed in the entire neural plate (Obendorf et al., 2007; Shimamura et al., 1995). This mating
would allow for total loss of FRS3 at a very early stage in the brain, assessing brain-specific loss
of FRS3 and its consequences. Secondly, mating a floxed FRS3 mouse line with a tamoxifen-
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inducible Cre-recombinase line (Daniellan et al., 1998) would allow for loss of FRS3 at desired
time points. Consequently, time-course experiments could be conducted where administration of
tamoxifen would result in loss of FRS3 at differing ages. Valuable experiments from these
knockdowns include immunohistochemistry on brain slices in order to visualize any changes in
neurogenesis (eg. relative amounts of glial cells vs neurons), neuron migration, as well as
behavioural and developmental differences.
At this point it is still necessary to address whether FRS3 has a direct affect on
microtubule stability. To this end, purified microtubules can be assembled from tubulin in the
presence or absence of purified FRS3 and the degree of corresponding microtubule
disassembly/depolymerization (upon dilution) can be measured in absorbance (Sun et al., 2011). It
would be of importance to next determine whether the interaction between FRS3 and its various
binding partners in the brain are direct or indirect via GST pulldowns. To this end, FRS3 can be
expressed in baculovirus infected insect cells and with the use of purified tubulin, an in vitro
microtubule binding assay can be performed. The use of infected cells provides a direct,
concentrated source of FRS3, as opposed to simply using brain lysate as the source of FRS3. Also,
in our lab we have various FRS3 mutant constructs available (mutated at both Grb2 and Shp2
binding site) that could be used in the microtubule in vitro binding assay or various coimmunoprecipitations in order to assess whether they retain the ability to bind microtubules or
other binding partners; this would help in deducing at what site the interaction between FRS3 and
microtubules/other binding partners occurs. Finally, in order to further elucidate the nature of the
interaction between FRS3 and microtubules, it would be of value to examine the structural and
dynamic properties of the microtubule complex and its association with specific domains of FRS3
and other microtubule associated proteins with the use of hydrogen/deuterium exchange coupled
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with mass spectrometry (HDX-MS) (Xiao et al., 2012).. This could be done in the presence or
absence of taxol (or even FRS3) while looking at where binding occurs and various
conformational changes that might arise. The HDX-MS method is ideal for probing interactions
occurring between protein-protein or protein-ligand complexes as it involves the comparison of
hydrogen-deuterium exchange rates of peptides before and after its interaction with binding
partners (Xiao et al., 2012).
Given the data presented in this thesis, it is fair to assume that the loss of FRS3 may play a
fundamental role in impaired neurological function, as proper cortex development is necessary for
normal brain function. This can include aspects such as behavior, learning and memory, as well as
motor skills; as such, it would be relevant to eventually pursue behavioral testing in mice,
assessing changes in locomotor activity, endurance, learning and memory, social behavior and
anxiety.
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Appendix
Solutions:
Bacterial Lysis Buffer I
50 mM Glucose
25 mM Tris-Cl (pH 8.0)
10 mM EDTA
Bacterial Lysis Buffer II
0.2 N NaOH
1% SDS
Bacterial Lysis Buffer III
3MK
5 M Acetic Acid
Blocking Buffer 1 (Immunocytochemistry)
5% Goat Serum
1.1% Triton-X 100
TBS to 10 mL
Blocking Buffer 2 (Western Blotting)
0.1% Tween-20
10% skim milk powder
Tris-buffered Saline (TBS)
Buffer A
0.1 M MES
1 mM MgSO4
2 mM EGTA
0.1 mM EDTA
4 M Glycerol
pH 6.75
Hanks Balanced Salt Solution (HBSS,2x)
140 mM NaCl
1.5mM NaH2PO4
50 mM HEPES
dH2O to 10 mL
HEK 293T Media
DMEM
450 mL
10% FBS
Gentamycin 500 μL
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Immunocytochemistry Blocking Buffer
5% Goat Serum
1.1% Triton-X 100
TBS to 10 mL
LB Media & Plates
5g biotryptone
2.5g yeast extract
5g NaCl
*H20 to 500mL
7.5g agar (plates only)
Neurobasal Maintenance Media (for neurons)
B27 Supplement
1mL
GlutaMAX
250 μL
50 uM gentamycin 50uL
Neurobasal
to 50 mL
NP-40 Lysis Buffer
50 mM Tris pH 8.0
137 mM NaCl
1 mM EDTA
1% NP-40
10% Glycerol
dH2O to 1 L
Phosphate Buffered Saline (PBS)
NaCl
8g
KCl
2g
NaH2PO4
1.44g
KH2PO4
dH2O
to 1 L
SDS Loading Dye (5x)
250 mM Tris-Cl pH 6.8
10% SDS
30% Glycerol
0.5 M Dithiothreitol (DTT)
0.02% Bromophenol Blue
SDS Page Buffer
25 mM Tris
192 mM Glycine
0.1% SDS
pH 8.3
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SN56 Cell Media
DMEM (-sodium pyruvate)
10% FBS
Gentamycin

450 mL
500 μL

Tris-Buffered Saline (TBS)
150 mM NaCl
10 mM Tris
pH 8.0
Lower Tris
1.5 M Tris-Cl
0.4 % SDS
pH 8.8

Upper Tris
0.5 M Tris-Cl
0.4 % SDS
pH 6.8

TBS-Tween (TBST)
1 M Tris pH 7.5
5M NaCl
0.1% Tween-20
dH2O

10 mL
20 mL
to 1 L

Tubulin Extraction Buffer
0.1M MES
1 mM MgSO4
2 mM EGTA
0.1 mM EDTA
4 M Glycerol
0.1% v/v Triton X-100
pH 6.75
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Figure 1: pRNAT U6.3/Hygro Vector map displaying shRNA sequences (Genscript)
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Table 1 Antibodies and their respective western blotting, immunoprecipitation and ICC dilutions.
Species
Antibodies
Western Blot Immunoprecipitation (μg/mL) ICC
Mouse

Acetylated  Tubulin
(T7451) Sigma Aldrich

1:10 000

1

1:2000

Mouse

Bassoon (ab82958)
Abcam

N/A

2

N/A

Mouse

B III Tubulin (T8660)
Sigma Aldrich

1:10 000

1

1:2000

Goat

Double Cortin (sc-8067)
Santa Cruz

N/A

4

N/A

Mouse

Kinesin HC (MAB1614)
Millipore

1:2000

5

1:250

Goat

Kinesin LC (sc13362)
Santa Cruz

1: 2000

4

1:250

Mouse

MAP2 (M9942)
Sigma Aldrich

1:5000

5

1:5000

Mouse

PSD-95 (sc-32290)
Santa Cruz

1:2000

N/A

N/A

Mouse

Shank 2 (sc-271834)
Santa Cruz

1:2000

4

1:200

Mouse

Shank 3 (ab93607)
Abcam

1:5000

2

N/A

Mouse

Syntaxin-1 (sc-12736)
Santa Cruz

1:2000

1

N/A

Mouse

Synaptophysin (ab8049)
Abcam

1:10 000

2

1:250

Goat

Tau (sc-1996)
Santa Cruz

1:2000

4

N/A

N/A

N/A

1:500

N/A

N/A

1:500

Goat anti-Rabbit secondary (A11008)
Alexa fluor
Goat anti-Mouse secondary (A11030)
Alexa fluor
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